Details of the Drug Combination

General Information of Drug Combination (ID: DCYIJUX)

Drug Combination Name
Isotretinoin Paclitaxel
Indication
Disease Entry Status REF
Lung Cancer Phase 1 [1]
Component Drugs Isotretinoin   DM4QTBN Paclitaxel   DMLB81S
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL 3D MOL

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
Indication(s) of Isotretinoin
Disease Entry ICD 11 Status REF
Acne vulgaris ED80 Approved [2]
Mycosis fungoides 2B01 Approved [3]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 3 [4]
Neuroblastoma 2D11.2 Investigative [3]
Isotretinoin Interacts with 2 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Retinoic acid receptor (RAR) TTOD7B3 NOUNIPROTAC Agonist [11]
COVID-19 papain-like proteinase (PL-PRO) TTNHMO8 R1AB_SARS2 (819-2763) Inhibitor [4]
------------------------------------------------------------------------------------
Isotretinoin Interacts with 1 DME Molecule(s)
DME Name DME ID UniProt ID Mode of Action REF
Cytochrome P450 3A4 (CYP3A4) DE4LYSA CP3A4_HUMAN Metabolism [12]
------------------------------------------------------------------------------------
Isotretinoin Interacts with 711 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Cytochrome P450 3A4 (CYP3A4) OTQGYY83 CP3A4_HUMAN Increases Activity [13]
AH receptor-interacting protein (AIP) OTDJ3OSV AIP_HUMAN Decreases Expression [6]
Suppressor of cytokine signaling 2 (SOCS2) OTBPNKJQ SOCS2_HUMAN Increases Expression [6]
Suppressor of cytokine signaling 1 (SOCS1) OTWA9KFU SOCS1_HUMAN Decreases Expression [6]
Transforming growth factor beta-1-induced transcript 1 protein (TGFB1I1) OTIK337D TGFI1_HUMAN Increases Expression [6]
RNA/RNP complex-1-interacting phosphatase (DUSP11) OTU6C41M DUS11_HUMAN Decreases Expression [6]
Lecithin retinol acyltransferase (LRAT) OTB7CJKY LRAT_HUMAN Increases Expression [6]
Keratin, type II cytoskeletal 75 (KRT75) OT28B9E6 K2C75_HUMAN Decreases Expression [6]
Epidermal growth factor receptor (EGFR) OTAPLO1S EGFR_HUMAN Decreases Expression [6]
Tissue-type plasminogen activator (PLAT) OTQPDNAB TPA_HUMAN Increases Expression [6]
Alpha-1-antichymotrypsin (SERPINA3) OT9BP2S0 AACT_HUMAN Increases Expression [6]
Keratin, type I cytoskeletal 14 (KRT14) OTUVZ1DW K1C14_HUMAN Decreases Expression [6]
Keratin, type II cytoskeletal 6A (KRT6A) OT392M5T K2C6A_HUMAN Decreases Expression [6]
Lysosomal acid glucosylceramidase (GBA1) OT0XMD63 GBA1_HUMAN Decreases Expression [6]
Keratin, type II cytoskeletal 1 (KRT1) OTIOJWA4 K2C1_HUMAN Decreases Expression [6]
Insulin-like growth factor I (IGF1) OTIIZR61 IGF1_HUMAN Increases Expression [6]
Protein S100-A8 (S100A8) OTVMOB3F S10A8_HUMAN Increases Expression [6]
Plasminogen activator inhibitor 2 (SERPINB2) OT72QLZB PAI2_HUMAN Decreases Expression [6]
Fibroblast growth factor 1 (FGF1) OT8I64X8 FGF1_HUMAN Decreases Expression [6]
Protein S100-A9 (S100A9) OTOARHCS S10A9_HUMAN Increases Expression [6]
Neurofilament light polypeptide (NEFL) OTQESJV4 NFL_HUMAN Decreases Expression [6]
Thrombospondin-1 (THBS1) OT0ECWK3 TSP1_HUMAN Decreases Expression [6]
Keratin, type I cytoskeletal 19 (KRT19) OTDGDQ75 K1C19_HUMAN Increases Expression [6]
Keratin, type II cytoskeletal 7 (KRT7) OTLT3JFN K2C7_HUMAN Increases Expression [6]
Stromelysin-2 (MMP10) OTJDWW8Q MMP10_HUMAN Decreases Expression [6]
Growth-regulated alpha protein (CXCL1) OT3WCTZV GROA_HUMAN Decreases Expression [6]
Glutathione S-transferase Mu 1 (GSTM1) OTSBF2MO GSTM1_HUMAN Decreases Expression [6]
Tumor-associated calcium signal transducer 2 (TACSTD2) OTLSZR00 TACD2_HUMAN Increases Expression [6]
Ornithine decarboxylase (ODC1) OTNDAGRR DCOR_HUMAN Decreases Expression [6]
Collagen alpha-1(VI) chain (COL6A1) OTYKSCOB CO6A1_HUMAN Decreases Expression [6]
Creatine kinase B-type (CKB) OTUCKOTT KCRB_HUMAN Decreases Expression [6]
Integrin alpha-4 (ITGA4) OTSCAL0V ITA4_HUMAN Increases Expression [6]
Keratin, type I cytoskeletal 10 (KRT10) OTSVRD3Q K1C10_HUMAN Decreases Expression [6]
Keratin, type II cytoskeletal 5 (KRT5) OTVGI9HT K2C5_HUMAN Decreases Expression [6]
Glutamine synthetase (GLUL) OTYGTCGF GLNA_HUMAN Increases Expression [6]
Keratin, type I cytoskeletal 15 (KRT15) OTS6WLF7 K1C15_HUMAN Increases Expression [6]
Lamin-B1 (LMNB1) OT100T3P LMNB1_HUMAN Increases Expression [6]
Filaggrin (FLG) OTE9QDV6 FILA_HUMAN Decreases Expression [6]
Cornifin-B (SPRR1B) OTXNW3P6 SPR1B_HUMAN Increases Expression [6]
Protein-glutamine gamma-glutamyltransferase K (TGM1) OTB8URRI TGM1_HUMAN Decreases Expression [6]
Prostaglandin G/H synthase 1 (PTGS1) OTHCRLEC PGH1_HUMAN Decreases Expression [6]
Protein S100-A1 (S100A1) OT1F2G4J S10A1_HUMAN Decreases Expression [6]
Laminin subunit alpha-2 (LAMA2) OTFROQWE LAMA2_HUMAN Decreases Expression [6]
Cytochrome P450 3A7 (CYP3A7) OTTCDHHM CP3A7_HUMAN Decreases Expression [6]
Deoxyribonuclease-1 (DNASE1) OTM4KWB3 DNAS1_HUMAN Increases Expression [6]
Collagen alpha-2(VIII) chain (COL8A2) OTASWJ69 CO8A2_HUMAN Decreases Expression [6]
11-beta-hydroxysteroid dehydrogenase 1 (HSD11B1) OTO7FJA9 DHI1_HUMAN Decreases Expression [6]
Protein S100-A7 (S100A7) OTJFVJRF S10A7_HUMAN Increases Expression [6]
Prostaglandin G/H synthase 2 (PTGS2) OT75U9M4 PGH2_HUMAN Decreases Expression [6]
Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (DLST) OTBDF9HJ ODO2_HUMAN Increases Expression [6]
Fatty acid synthase (FASN) OTFII9KG FAS_HUMAN Decreases Expression [6]
Cyclin-dependent kinase inhibitor 1C (CDKN1C) OTASTJ3Q CDN1C_HUMAN Decreases Expression [6]
Serpin B8 (SERPINB8) OT5T4Y5R SPB8_HUMAN Decreases Expression [6]
Serpin B9 (SERPINB9) OTJ811IF SPB9_HUMAN Decreases Expression [6]
Monocarboxylate transporter 1 (SLC16A1) OTW1UTZ7 MOT1_HUMAN Decreases Expression [6]
Epithelial membrane protein 1 (EMP1) OTSZHUHQ EMP1_HUMAN Increases Expression [6]
Microfibrillar-associated protein 2 (MFAP2) OTMHVBTV MFAP2_HUMAN Decreases Expression [6]
Transforming protein RhoA (RHOA) OT6YOJ9N RHOA_HUMAN Decreases Expression [6]
Rho-related GTP-binding protein RhoB (RHOB) OTHQFQF7 RHOB_HUMAN Decreases Expression [6]
Neutrophil gelatinase-associated lipocalin (LCN2) OTSB42BR NGAL_HUMAN Increases Expression [6]
Fatty acid-binding protein 5 (FABP5) OTNM186C FABP5_HUMAN Decreases Expression [6]
Sterol 26-hydroxylase, mitochondrial (CYP27A1) OT649C01 CP27A_HUMAN Decreases Expression [6]
Cytochrome P450 4A11 (CYP4A11) OTPU5J0S CP4AB_HUMAN Decreases Expression [6]
Keratin, type I cytoskeletal 17 (KRT17) OT6Y1DPK K1C17_HUMAN Decreases Expression [6]
Sulfotransferase 2A1 (SULT2A1) OT0ISKQ4 ST2A1_HUMAN Increases Expression [6]
Desmocollin-1 (DSC1) OTNII6GZ DSC1_HUMAN Decreases Expression [6]
Interleukin-24 (IL24) OT4VUWH1 IL24_HUMAN Decreases Expression [6]
Chromobox protein homolog 3 (CBX3) OTOP9RLD CBX3_HUMAN Decreases Expression [6]
Eukaryotic translation initiation factor 4E-binding protein 2 (EIF4EBP2) OT3M8WEU 4EBP2_HUMAN Decreases Expression [6]
Interleukin-10 receptor subunit alpha (IL10RA) OTOX3D1D I10R1_HUMAN Decreases Expression [6]
Fas-activated serine/threonine kinase (FASTK) OTTHFZMP FASTK_HUMAN Decreases Expression [6]
Peptidyl-prolyl cis-trans isomerase FKBP8 (FKBP8) OT8RPSOC FKBP8_HUMAN Decreases Expression [6]
Growth factor receptor-bound protein 7 (GRB7) OTF8Y9XY GRB7_HUMAN Decreases Expression [6]
Enhancer of filamentation 1 (NEDD9) OTGCFN4M CASL_HUMAN Increases Expression [6]
Laminin subunit alpha-3 (LAMA3) OTFME7HT LAMA3_HUMAN Decreases Expression [6]
Proheparin-binding EGF-like growth factor (HBEGF) OTLU00JS HBEGF_HUMAN Increases Expression [6]
E3 ubiquitin-protein ligase RNF5 (RNF5) OTDQGI37 RNF5_HUMAN Decreases Expression [6]
Growth/differentiation factor 15 (GDF15) OTWQN50N GDF15_HUMAN Increases Expression [6]
Growth/differentiation factor 2 (GDF2) OTRB5L04 GDF2_HUMAN Increases Expression [6]
Collagen alpha-1(XVII) chain (COL17A1) OTID5AH2 COHA1_HUMAN Decreases Expression [6]
Laminin subunit gamma-3 (LAMC3) OTKNAYJO LAMC3_HUMAN Increases Expression [6]
Dual specificity protein phosphatase 10 (DUSP10) OTNG467B DUS10_HUMAN Increases Expression [6]
Cytochrome P450 26A1 (CYP26A1) OTL1DFWV CP26A_HUMAN Increases Expression [14]
N-myc proto-oncogene protein (MYCN) OTWD33K1 MYCN_HUMAN Decreases Expression [15]
Retinoic acid receptor beta (RARB) OT367U3E RARB_HUMAN Increases Expression [15]
Cellular retinoic acid-binding protein 2 (CRABP2) OTY01V9G RABP2_HUMAN Increases Expression [15]
Cytochrome P450 26B1 (CYP26B1) OT92XA92 CP26B_HUMAN Increases Expression [15]
Class E basic helix-loop-helix protein 40 (BHLHE40) OTITX14U BHE40_HUMAN Increases Expression [7]
FYN-binding protein 1 (FYB1) OT6345CH FYB1_HUMAN Increases Expression [7]
Short-chain dehydrogenase/reductase 3 (DHRS3) OTSK1DTP DHRS3_HUMAN Increases Expression [7]
Tight junction protein ZO-3 (TJP3) OTC1K8HC ZO3_HUMAN Increases Expression [7]
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (GCNT3) OTQ9ALTR GCNT3_HUMAN Increases Expression [7]
Osteopontin (SPP1) OTJGC23Y OSTP_HUMAN Increases Expression [7]
Insulin-like growth factor-binding protein 3 (IGFBP3) OTIX63TX IBP3_HUMAN Increases Expression [7]
Stress-induced-phosphoprotein 1 (STIP1) OT7TXLOX STIP1_HUMAN Decreases Expression [7]
Cadherin-5 (CDH5) OTVX0E1Q CADH5_HUMAN Increases Expression [7]
Amiloride-sensitive sodium channel subunit alpha (SCNN1A) OTE2KVZV SCNNA_HUMAN Increases Expression [7]
Tumor necrosis factor ligand superfamily member 10 (TNFSF10) OT4PXBTA TNF10_HUMAN Increases Expression [7]
E3 ubiquitin-protein ligase TRIM22 (TRIM22) OTJBLG5R TRI22_HUMAN Increases Expression [7]
E3 ubiquitin-protein ligase TRIM31 (TRIM31) OT7VW6RP TRI31_HUMAN Increases Expression [7]
Small proline-rich protein 3 (SPRR3) OTN9QJKG SPRR3_HUMAN Decreases Expression [7]
Diphosphoinositol polyphosphate phosphohydrolase NUDT4B (NUDT4) OTA6ICI2 NUD4B_HUMAN Decreases Expression [8]
Putative glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial (GATD3) OTBQRU82 GAL3B_HUMAN Decreases Expression [8]
RNA-binding protein 47 (RBM47) OT6W67VM RBM47_HUMAN Decreases Expression [8]
Transcription factor E2F8 (E2F8) OTQKZGFP E2F8_HUMAN Decreases Expression [8]
Protein FAM149A (FAM149A) OTMDM0RI F149A_HUMAN Increases Expression [8]
Potassium channel subfamily K member 1 (KCNK1) OTBXPTKX KCNK1_HUMAN Decreases Expression [8]
NADH dehydrogenase iron-sulfur protein 8, mitochondrial (NDUFS8) OTMEAWKO NDUS8_HUMAN Decreases Expression [8]
Membrane-associated progesterone receptor component 1 (PGRMC1) OTBE6WAC PGRC1_HUMAN Decreases Expression [8]
Huntingtin-interacting protein 1 (HIP1) OT7AKCFQ HIP1_HUMAN Increases Expression [8]
Pyruvate dehydrogenase protein X component, mitochondrial (PDHX) OTG7O271 ODPX_HUMAN Decreases Expression [8]
RNA 3'-terminal phosphate cyclase (RTCA) OTSJRVTD RTCA_HUMAN Decreases Expression [8]
Interferon-related developmental regulator 1 (IFRD1) OT4SQMLQ IFRD1_HUMAN Decreases Expression [8]
RNA polymerase II elongation factor ELL2 (ELL2) OTZJRTFM ELL2_HUMAN Decreases Expression [8]
Butyrophilin subfamily 3 member A3 (BTN3A3) OTKMSJRA BT3A3_HUMAN Increases Expression [8]
Ribonuclease T2 (RNASET2) OTWY64L7 RNT2_HUMAN Increases Expression [8]
Pirin (PIR) OT8ALXHU PIR_HUMAN Decreases Expression [8]
Peroxisomal targeting signal 2 receptor (PEX7) OTM7VBRC PEX7_HUMAN Decreases Expression [8]
Fructose-1,6-bisphosphatase isozyme 2 (FBP2) OT9R1LF7 F16P2_HUMAN Decreases Expression [8]
Pyridoxal kinase (PDXK) OT40AJ5J PDXK_HUMAN Decreases Expression [8]
Phospholipid phosphatase 3 (PLPP3) OTSSF7BK PLPP3_HUMAN Increases Expression [8]
Immunoglobulin superfamily containing leucine-rich repeat protein (ISLR) OTOLYLGI ISLR_HUMAN Increases Expression [8]
Homeobox protein cut-like 2 (CUX2) OTDJTQAJ CUX2_HUMAN Decreases Expression [8]
Testis-specific basic protein Y 2 (BPY2) OT2WQPNQ VCY2_HUMAN Decreases Expression [8]
Etoposide-induced protein 2.4 homolog (EI24) OTD4NOYS EI24_HUMAN Decreases Expression [8]
Proteasome subunit alpha type-7 (PSMA7) OTPHI6ST PSA7_HUMAN Decreases Expression [8]
Mitochondrial import inner membrane translocase subunit Tim23 (TIMM23) OTAAS85T TIM23_HUMAN Decreases Expression [8]
Long-chain fatty acid transport protein 2 (SLC27A2) OT7JEG5F S27A2_HUMAN Decreases Expression [8]
NPC intracellular cholesterol transporter 1 (NPC1) OTRIPICX NPC1_HUMAN Decreases Expression [8]
Secretory carrier-associated membrane protein 1 (SCAMP1) OTFS4IKJ SCAM1_HUMAN Decreases Expression [8]
Dihydroxyacetone phosphate acyltransferase (GNPAT) OTF6LWPO GNPAT_HUMAN Decreases Expression [8]
Polyunsaturated fatty acid lipoxygenase ALOX15B (ALOX15B) OTWQQ08W LX15B_HUMAN Decreases Expression [8]
Inositol polyphosphate 4-phosphatase type II (INPP4B) OTLROA7G INP4B_HUMAN Decreases Expression [8]
Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT2) OT8L6EGI BCAT2_HUMAN Decreases Expression [8]
High affinity copper uptake protein 1 (SLC31A1) OTXLRTUB COPT1_HUMAN Decreases Expression [8]
Insulin-induced gene 1 protein (INSIG1) OTZF5X1D INSI1_HUMAN Decreases Expression [8]
Fatty acid-binding protein, brain (FABP7) OTRE2H4G FABP7_HUMAN Decreases Expression [8]
D-3-phosphoglycerate dehydrogenase (PHGDH) OT1LMRTG SERA_HUMAN Increases Expression [8]
Cochlin (COCH) OTBEHD89 COCH_HUMAN Increases Expression [8]
Tetraspanin-6 (TSPAN6) OT8X0NWN TSN6_HUMAN Decreases Expression [8]
NADH dehydrogenase 1 beta subcomplex subunit 3 (NDUFB3) OTDV12IF NDUB3_HUMAN Decreases Expression [8]
Maleylacetoacetate isomerase (GSTZ1) OTQ43JCE MAAI_HUMAN Decreases Expression [8]
Synaptogyrin-1 (SYNGR1) OT0MBUK5 SNG1_HUMAN Decreases Expression [8]
Peroxisomal membrane protein PMP34 (SLC25A17) OT2TUHO8 PM34_HUMAN Decreases Expression [8]
Cleavage and polyadenylation specificity factor subunit 5 (NUDT21) OTZHKWAR CPSF5_HUMAN Decreases Expression [8]
Sushi domain-containing protein 5 (SUSD5) OTIMJGDH SUSD5_HUMAN Increases Expression [8]
Acyl-CoA (FADS1) OTUYOYHX FADS1_HUMAN Decreases Expression [8]
Lipid transferase CIDEA (CIDEA) OTDUTSOV CIDEA_HUMAN Decreases Expression [8]
Monocarboxylate transporter 2 (SLC16A7) OT7OI36B MOT2_HUMAN Decreases Expression [8]
Sushi repeat-containing protein SRPX2 (SRPX2) OT6A63TX SRPX2_HUMAN Decreases Expression [8]
Dual specificity protein phosphatase CDC14B (CDC14B) OTAESVOZ CC14B_HUMAN Increases Expression [8]
Histone H2B type 1-K (H2BC12) OTQ8V0KG H2B1K_HUMAN Decreases Expression [8]
Checkpoint protein HUS1 (HUS1) OTY1XON9 HUS1_HUMAN Decreases Expression [8]
Nibrin (NBN) OT73B5MD NBN_HUMAN Decreases Expression [8]
Slit homolog 3 protein (SLIT3) OTU8MKEU SLIT3_HUMAN Increases Expression [8]
Microfibrillar-associated protein 3-like (MFAP3L) OTNMHSAH MFA3L_HUMAN Decreases Expression [8]
Peroxisomal membrane protein 11A (PEX11A) OT8MJ9CJ PX11A_HUMAN Decreases Expression [8]
NADH dehydrogenase iron-sulfur protein 7, mitochondrial (NDUFS7) OTIRMB2O NDUS7_HUMAN Decreases Expression [8]
Large ribosomal subunit protein bL33m (MRPL33) OTA3YDH0 RM33_HUMAN Decreases Expression [8]
Mitochondrial-processing peptidase subunit beta (PMPCB) OTRMBHNM MPPB_HUMAN Decreases Expression [8]
NADH dehydrogenase iron-sulfur protein 3, mitochondrial (NDUFS3) OTX61TQQ NDUS3_HUMAN Decreases Expression [8]
Protein phosphatase 1B (PPM1B) OTZMH6V3 PPM1B_HUMAN Decreases Expression [8]
Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma (PIK3C2G) OTW3LY1C P3C2G_HUMAN Decreases Expression [8]
Ribonuclease P protein subunit p40 (RPP40) OTRYY1AP RPP40_HUMAN Decreases Expression [8]
Lathosterol oxidase (SC5D) OT41KMW4 SC5D_HUMAN Decreases Expression [8]
Isocitrate dehydrogenase cytoplasmic (IDH1) OT4DLHC8 IDHC_HUMAN Decreases Expression [8]
Matrix metalloproteinase-23 (MMP23B) OT2OR6TS MMP23_HUMAN Increases Expression [8]
Carboxypeptidase D (CPD) OT2CS64Y CBPD_HUMAN Decreases Expression [8]
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial (CLPX) OTIT4JL0 CLPX_HUMAN Decreases Expression [8]
Delta(14)-sterol reductase TM7SF2 (TM7SF2) OTILU5S7 ERG24_HUMAN Decreases Expression [8]
Mitochondrial import receptor subunit TOM70 (TOMM70) OT8QBYZ0 TOM70_HUMAN Decreases Expression [8]
Rho-related BTB domain-containing protein 3 (RHOBTB3) OT1BFKPH RHBT3_HUMAN Increases Expression [8]
NADH dehydrogenase 1 alpha subcomplex subunit 3 (NDUFA3) OTXL10N9 NDUA3_HUMAN Decreases Expression [8]
RasGAP-activating-like protein 1 (RASAL1) OTAHUNN7 RASL1_HUMAN Decreases Expression [8]
NADH dehydrogenase 1 subunit C2 (NDUFC2) OT9M119L NDUC2_HUMAN Decreases Expression [8]
CUGBP Elav-like family member 2 (CELF2) OTLJJ4VT CELF2_HUMAN Increases Expression [8]
NAD kinase (NADK) OTYN9GX0 NADK_HUMAN Decreases Expression [8]
Mitochondrial pyruvate carrier 2 (MPC2) OT0GHXGG MPC2_HUMAN Decreases Expression [8]
Fatty acid CoA ligase Acsl3 (ACSL3) OT3MWER1 ACSL3_HUMAN Decreases Expression [8]
STAM-binding protein (STAMBP) OTOT2OXM STABP_HUMAN Decreases Expression [8]
GTP-binding protein Di-Ras3 (DIRAS3) OT3XHLQA DIRA3_HUMAN Decreases Expression [8]
Geranylgeranyl pyrophosphate synthase (GGPS1) OTVEHG28 GGPPS_HUMAN Decreases Expression [8]
Apoptosis-inducing factor 1, mitochondrial (AIFM1) OTKPWB7Q AIFM1_HUMAN Decreases Expression [8]
Acyl-CoA 6-desaturase (FADS2) OTUX531P FADS2_HUMAN Decreases Expression [8]
EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2) OT0I2B4J FBLN4_HUMAN Increases Expression [8]
Anterior gradient protein 2 homolog (AGR2) OTRRZT7W AGR2_HUMAN Decreases Expression [8]
Cytochrome b5 (CYB5A) OT6SN4RM CYB5_HUMAN Decreases Expression [8]
Dihydrofolate reductase (DHFR) OT3DVIGM DYR_HUMAN Decreases Expression [8]
Complement C1r subcomponent (C1R) OTA0ZNIU C1R_HUMAN Increases Expression [8]
2'-5'-oligoadenylate synthase 1 (OAS1) OT8ZLOCY OAS1_HUMAN Decreases Expression [8]
Alpha-2-macroglobulin (A2M) OTFTX90K A2MG_HUMAN Increases Expression [8]
Complement C3 (C3) OTCH5GS0 CO3_HUMAN Increases Expression [8]
Cystatin-C (CST3) OTNZ6AO4 CYTC_HUMAN Increases Expression [8]
GTPase KRas (KRAS) OT78QCN8 RASK_HUMAN Decreases Expression [8]
Low-density lipoprotein receptor (LDLR) OTH559LU LDLR_HUMAN Decreases Expression [8]
Interleukin-1 beta (IL1B) OT0DWXXB IL1B_HUMAN Decreases Expression [8]
HLA class II histocompatibility antigen, DQ beta 1 chain (HLA-DQB1) OTVVI3UI DQB1_HUMAN Increases Expression [8]
Apolipoprotein C-I (APOC1) OTA58CED APOC1_HUMAN Decreases Expression [8]
Fibronectin (FN1) OTB5ZN4Q FINC_HUMAN Increases Expression [8]
Transferrin receptor protein 1 (TFRC) OT8ZPBDL TFR1_HUMAN Decreases Expression [8]
3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) OTRT3F3U HMDH_HUMAN Decreases Expression [8]
Cystatin-B (CSTB) OT3U0JF8 CYTB_HUMAN Decreases Expression [8]
Superoxide dismutase , mitochondrial (SOD2) OTIWXGZ9 SODM_HUMAN Decreases Expression [8]
T-cell surface glycoprotein CD3 delta chain (CD3D) OTRBLP0R CD3D_HUMAN Increases Expression [8]
HLA class II histocompatibility antigen, DP beta 1 chain (HLA-DPB1) OTW8JHU2 DPB1_HUMAN Increases Expression [8]
Histone H2A type 1-B/E (H2AC4) OTMFQ662 H2A1B_HUMAN Decreases Expression [8]
Integrin beta-2 (ITGB2) OTEKPEPR ITB2_HUMAN Increases Expression [8]
Plasma protease C1 inhibitor (SERPING1) OT6CVN45 IC1_HUMAN Increases Expression [8]
Propionyl-CoA carboxylase beta chain, mitochondrial (PCCB) OTXUN47K PCCB_HUMAN Decreases Expression [8]
HLA class II histocompatibility antigen, DQ beta 2 chain (HLA-DQB2) OTZYAIBF DQB2_HUMAN Increases Expression [8]
Collagen alpha-2(V) chain (COL5A2) OT5VOSQE CO5A2_HUMAN Increases Expression [8]
Tyrosine-protein kinase Lck (LCK) OT883FG9 LCK_HUMAN Increases Expression [8]
T-cell surface antigen CD2 (CD2) OTLYO0DB CD2_HUMAN Increases Expression [8]
Eukaryotic translation initiation factor 4E (EIF4E) OTDAWNLA IF4E_HUMAN Decreases Expression [8]
Integrin alpha-V (ITGAV) OTAM7JTR ITAV_HUMAN Increases Expression [8]
Acyl-CoA-binding protein (DBI) OT884QY9 ACBP_HUMAN Decreases Expression [8]
Vitamin K-dependent protein S (PROS1) OTXQWNOI PROS_HUMAN Increases Expression [8]
Macrophage colony-stimulating factor 1 receptor (CSF1R) OTDYTB9C CSF1R_HUMAN Increases Expression [8]
Tyrosine-protein kinase Lyn (LYN) OTP686K2 LYN_HUMAN Increases Expression [8]
Fumarate hydratase, mitochondrial (FH) OTEQWU6Q FUMH_HUMAN Decreases Expression [8]
DNA excision repair protein ERCC-1 (ERCC1) OTNPYQHI ERCC1_HUMAN Decreases Expression [8]
Beta-microseminoprotein (MSMB) OTYORAJC MSMB_HUMAN Increases Expression [8]
72 kDa type IV collagenase (MMP2) OT5NIWA2 MMP2_HUMAN Increases Expression [8]
Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (PDHA1) OTGEU8IK ODPA_HUMAN Decreases Expression [8]
Collagen alpha-2(IV) chain (COL4A2) OTJK1LKN CO4A2_HUMAN Increases Expression [8]
Receptor-type tyrosine-protein phosphatase C (PTPRC) OT6KOR77 PTPRC_HUMAN Increases Expression [8]
Keratin, type I cytoskeletal 16 (KRT16) OTGA0EQN K1C16_HUMAN Decreases Expression [8]
Alpha-2A adrenergic receptor (ADRA2A) OTZFGOTP ADA2A_HUMAN Increases Expression [8]
3-ketoacyl-CoA thiolase, peroxisomal (ACAA1) OTVKRET0 THIK_HUMAN Decreases Expression [8]
Fructose-1,6-bisphosphatase 1 (FBP1) OTQBANEP F16P1_HUMAN Decreases Expression [8]
Platelet-derived growth factor receptor beta (PDGFRB) OTYSNK9Q PGFRB_HUMAN Increases Expression [8]
Dihydrolipoyl dehydrogenase, mitochondrial (DLD) OT378CU9 DLDH_HUMAN Decreases Expression [8]
Complement C1s subcomponent (C1S) OTCIZU2A C1S_HUMAN Increases Expression [8]
Histone H2A type 1 (H2AC11) OTN9P0BO H2A1_HUMAN Decreases Expression [8]
Myocardial zonula adherens protein (MYZAP) OTAZCNBT MYZAP_HUMAN Increases Expression [8]
RNA-binding protein RO60 (RO60) OTLGM5A8 RO60_HUMAN Decreases Expression [8]
COUP transcription factor 1 (NR2F1) OTGWZWYL COT1_HUMAN Increases Expression [8]
Cytochrome c oxidase subunit 5B, mitochondrial (COX5B) OTDP94F3 COX5B_HUMAN Decreases Expression [8]
60 kDa heat shock protein, mitochondrial (HSPD1) OTTO1Y11 CH60_HUMAN Decreases Expression [8]
Laminin subunit gamma-1 (LAMC1) OTIG527N LAMC1_HUMAN Increases Expression [8]
Leukocyte antigen CD37 (CD37) OT92HV6X CD37_HUMAN Increases Expression [8]
Hepatic triacylglycerol lipase (LIPC) OTZY5SC9 LIPC_HUMAN Increases Expression [8]
Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHB) OT2NHE5E ODPB_HUMAN Decreases Expression [8]
Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (DBT) OT4KZ5R9 ODB2_HUMAN Decreases Expression [8]
Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADM) OTA4P0FC ACADM_HUMAN Decreases Expression [8]
Fibroblast growth factor receptor 1 (FGFR1) OT4GLCXW FGFR1_HUMAN Increases Expression [8]
Glucose-6-phosphate 1-dehydrogenase (G6PD) OT300SMK G6PD_HUMAN Decreases Expression [8]
Cytochrome c oxidase subunit 6A1, mitochondrial (COX6A1) OT77MV8G CX6A1_HUMAN Decreases Expression [8]
Collagen alpha-2(VI) chain (COL6A2) OTQC6PPO CO6A2_HUMAN Increases Expression [8]
Collagen alpha-3(VI) chain (COL6A3) OTAS6R6I CO6A3_HUMAN Increases Expression [8]
Myosin light chain 4 (MYL4) OTURFCSE MYL4_HUMAN Decreases Expression [8]
Interferon-induced transmembrane protein 1 (IFITM1) OTECO1G8 IFM1_HUMAN Increases Expression [8]
5-aminolevulinate synthase, non-specific, mitochondrial (ALAS1) OTQY6ZSF HEM1_HUMAN Decreases Expression [8]
Intercellular adhesion molecule 2 (ICAM2) OT3E070F ICAM2_HUMAN Increases Expression [8]
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) OTPWI88U CEAM1_HUMAN Decreases Expression [8]
HLA class I histocompatibility antigen, alpha chain E (HLA-E) OTX1CTFB HLAE_HUMAN Increases Expression [8]
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 (HSD3B1) OTNAZVKB 3BHS1_HUMAN Decreases Expression [8]
Hematopoietic lineage cell-specific protein (HCLS1) OTX7WGYN HCLS1_HUMAN Increases Expression [8]
Farnesyl pyrophosphate synthase (FDPS) OT6CKWV5 FPPS_HUMAN Decreases Expression [8]
Cytochrome c oxidase subunit 7A2, mitochondrial (COX7A2) OTVT146E CX7A2_HUMAN Decreases Expression [8]
Aldo-keto reductase family 1 member A1 (AKR1A1) OTZT9NOW AK1A1_HUMAN Decreases Expression [8]
Endoplasmin (HSP90B1) OT02XLBR ENPL_HUMAN Decreases Expression [8]
Serine/threonine-protein kinase B-raf (BRAF) OT7S81XQ BRAF_HUMAN Decreases Expression [8]
Ras-related C3 botulinum toxin substrate 2 (RAC2) OTAOHFNH RAC2_HUMAN Increases Expression [8]
Myoblast determination protein 1 (MYOD1) OTV2S79X MYOD1_HUMAN Decreases Expression [8]
Mucin-1 (MUC1) OTHQI7IY MUC1_HUMAN Decreases Expression [8]
Ribosyldihydronicotinamide dehydrogenase (NQO2) OTGDAJRZ NQO2_HUMAN Decreases Expression [8]
Histone H2AX (H2AX) OT18UX57 H2AX_HUMAN Decreases Expression [8]
Solute carrier family 25 member 16 (SLC25A16) OTTTUL91 GDC_HUMAN Decreases Expression [8]
Histone H1.2 (H1-2) OT0AVI4M H12_HUMAN Decreases Expression [8]
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (PDE6A) OTPUTR2K PDE6A_HUMAN Decreases Expression [8]
HLA class I histocompatibility antigen, alpha chain G (HLA-G) OTMLK1KN HLAG_HUMAN Increases Expression [8]
3-oxo-5-alpha-steroid 4-dehydrogenase 1 (SRD5A1) OTQRET2B S5A1_HUMAN Decreases Expression [8]
NADH dehydrogenase flavoprotein 2, mitochondrial (NDUFV2) OTSZF7D6 NDUV2_HUMAN Decreases Expression [8]
HLA class II histocompatibility antigen, DP alpha 1 chain (HLA-DPA1) OT7OG7Y2 DPA1_HUMAN Increases Expression [8]
Tryptase beta-2 (TPSB2) OTN769MT TRYB2_HUMAN Increases Expression [8]
Cytochrome c oxidase subunit 5A, mitochondrial (COX5A) OTP0961M COX5A_HUMAN Decreases Expression [8]
Aromatic-L-amino-acid decarboxylase (DDC) OT0TSW09 DDC_HUMAN Decreases Expression [8]
Collagen alpha-1(V) chain (COL5A1) OT24078H CO5A1_HUMAN Increases Expression [8]
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase (AGA) OTNWT1WB ASPG_HUMAN Decreases Expression [8]
Filamin-A (FLNA) OTYZ9JXM FLNA_HUMAN Increases Expression [8]
Cytoplasmic aconitate hydratase (ACO1) OT2VUR7L ACOHC_HUMAN Decreases Expression [8]
Biglycan (BGN) OT3AV6IF PGS1_HUMAN Increases Expression [8]
2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (BCKDHB) OT8OSVYU ODBB_HUMAN Decreases Expression [8]
Tenascin-X (TNXB) OTVBWAV5 TENX_HUMAN Increases Expression [8]
Glutathione peroxidase 3 (GPX3) OT6PK94R GPX3_HUMAN Decreases Expression [8]
Galanin peptides (GAL) OTB3VPTO GALA_HUMAN Decreases Expression [8]
Fibroblast growth factor receptor 3 (FGFR3) OTSAXDIL FGFR3_HUMAN Increases Expression [8]
Insulin-like growth factor-binding protein 4 (IGFBP4) OT2HZRBD IBP4_HUMAN Increases Expression [8]
Fibulin-1 (FBLN1) OT5MHHOP FBLN1_HUMAN Increases Expression [8]
Glycine dehydrogenase (GLDC) OTVVDNW0 GCSP_HUMAN Decreases Expression [8]
Glycine cleavage system H protein, mitochondrial (GCSH) OTNC1OKA GCSH_HUMAN Decreases Expression [8]
Tyrosine-protein kinase JAK1 (JAK1) OT0X3D17 JAK1_HUMAN Increases Expression [8]
Receptor-type tyrosine-protein phosphatase beta (PTPRB) OTCQPLGZ PTPRB_HUMAN Increases Expression [8]
Receptor-type tyrosine-protein phosphatase gamma (PTPRG) OT9N2WOF PTPRG_HUMAN Increases Expression [8]
Plasma membrane calcium-transporting ATPase 4 (ATP2B4) OTMWFDAC AT2B4_HUMAN Increases Expression [8]
Carnitine O-palmitoyltransferase 2, mitochondrial (CPT2) OTIN6G20 CPT2_HUMAN Decreases Expression [8]
Cytochrome c oxidase subunit 7B, mitochondrial (COX7B) OT67PIDP COX7B_HUMAN Decreases Expression [8]
Insulin-like growth factor-binding protein 5 (IGFBP5) OTRE5V0C IBP5_HUMAN Increases Expression [8]
Proteasome subunit alpha type-1 (PSMA1) OTNBVM2U PSA1_HUMAN Decreases Expression [8]
Proteasome subunit alpha type-3 (PSMA3) OT52M10V PSA3_HUMAN Decreases Expression [8]
Proteasome subunit alpha type-4 (PSMA4) OTAD2XXI PSA4_HUMAN Decreases Expression [8]
Rhombotin-2 (LMO2) OTCC370G RBTN2_HUMAN Increases Expression [8]
Protein S100-A4 (S100A4) OTLRGFSQ S10A4_HUMAN Increases Expression [8]
V-type proton ATPase 16 kDa proteolipid subunit c (ATP6V0C) OTKPL09B VATL_HUMAN Decreases Expression [8]
Calmodulin-like protein 3 (CALML3) OTM8DNQU CALL3_HUMAN Decreases Expression [8]
Microtubule-associated protein 4 (MAP4) OT78YX9J MAP4_HUMAN Increases Expression [8]
Interleukin-1 receptor type 2 (IL1R2) OT0G7E35 IL1R2_HUMAN Decreases Expression [8]
Proteasome subunit alpha type-5 (PSMA5) OT38E6Y1 PSA5_HUMAN Decreases Expression [8]
Proteasome subunit beta type-5 (PSMB5) OTOZXAS6 PSB5_HUMAN Decreases Expression [8]
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (NDUFS1) OTTIZDFR NDUS1_HUMAN Decreases Expression [8]
Receptor-type tyrosine-protein phosphatase mu (PTPRM) OTCEL6PN PTPRM_HUMAN Increases Expression [8]
Hematopoietic progenitor cell antigen CD34 (CD34) OT1MOFLZ CD34_HUMAN Increases Expression [8]
Transketolase (TKT) OTT5KPUB TKT_HUMAN Decreases Expression [8]
Flavin reductase (BLVRB) OTHCFN2C BLVRB_HUMAN Decreases Expression [8]
D-dopachrome decarboxylase (DDT) OTF5HTYL DOPD_HUMAN Decreases Expression [8]
Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIF) OTRA8ZVE PPIF_HUMAN Decreases Expression [8]
HLA class I histocompatibility antigen, alpha chain F (HLA-F) OT76CM19 HLAF_HUMAN Increases Expression [8]
Pyruvate kinase PKLR (PKLR) OTTTM1QI KPYR_HUMAN Decreases Expression [8]
CAMPATH-1 antigen (CD52) OT02LDQN CD52_HUMAN Increases Expression [8]
Peroxiredoxin-2 (PRDX2) OTLWCY9T PRDX2_HUMAN Decreases Expression [8]
Glycerol kinase (GK) OTK2YRA0 GLPK_HUMAN Decreases Expression [8]
Cytidine deaminase (CDA) OT3HXP6N CDD_HUMAN Decreases Expression [8]
Cystathionine gamma-lyase (CTH) OTC90LA0 CGL_HUMAN Decreases Expression [8]
Melanocortin receptor 5 (MC5R) OTY11L4A MC5R_HUMAN Decreases Expression [8]
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA (MAN1A1) OT6LIGJP MA1A1_HUMAN Increases Expression [8]
Serine hydroxymethyltransferase, cytosolic (SHMT1) OTIINA3J GLYC_HUMAN Decreases Expression [8]
Nuclear receptor ROR-alpha (RORA) OTGQT12P RORA_HUMAN Decreases Expression [8]
Thrombospondin-4 (THBS4) OTA1T9KK TSP4_HUMAN Increases Expression [8]
Sterol O-acyltransferase 1 (SOAT1) OTB4Y5RJ SOAT1_HUMAN Decreases Expression [8]
Basigin (BSG) OTD0CVEC BASI_HUMAN Decreases Expression [8]
Metalloproteinase inhibitor 3 (TIMP3) OTDGQAD1 TIMP3_HUMAN Increases Expression [8]
Chitinase-3-like protein 1 (CHI3L1) OT2Z7VJH CH3L1_HUMAN Decreases Expression [8]
ATP synthase subunit gamma, mitochondrial (ATP5F1C) OTV5GZK5 ATPG_HUMAN Decreases Expression [8]
Phosphoglucomutase-1 (PGM1) OT3VM4JX PGM1_HUMAN Decreases Expression [8]
TGF-beta receptor type-2 (TGFBR2) OT3P7GZP TGFR2_HUMAN Increases Expression [8]
Squalene synthase (FDFT1) OTGDISIT FDFT_HUMAN Decreases Expression [8]
Transaldolase (TALDO1) OTDKV2S2 TALDO_HUMAN Decreases Expression [8]
Vitamin K-dependent gamma-carboxylase (GGCX) OTE0FNAP VKGC_HUMAN Decreases Expression [8]
Stress-70 protein, mitochondrial (HSPA9) OT4TMVS9 GRP75_HUMAN Decreases Expression [8]
Cyclin-dependent kinase inhibitor 1 (CDKN1A) OTQWHCZE CDN1A_HUMAN Decreases Expression [8]
Peroxisomal biogenesis factor 19 (PEX19) OTQIDE9Z PEX19_HUMAN Decreases Expression [8]
Chloride anion exchanger (SLC26A3) OTBNK2U2 S26A3_HUMAN Decreases Expression [8]
Malate dehydrogenase, cytoplasmic (MDH1) OTJEO4E8 MDHC_HUMAN Decreases Expression [8]
Melanocyte protein PMEL (PMEL) OTCDDHHM PMEL_HUMAN Decreases Expression [8]
Prostaglandin-H2 D-isomerase (PTGDS) OT71NN7C PTGDS_HUMAN Increases Expression [8]
Enoyl-CoA delta isomerase 1, mitochondrial (ECI1) OTRQTK84 ECI1_HUMAN Decreases Expression [8]
3-ketoacyl-CoA thiolase, mitochondrial (ACAA2) OTGLVWOP THIM_HUMAN Decreases Expression [8]
Carnitine O-acetyltransferase (CRAT) OTSCLZ04 CACP_HUMAN Decreases Expression [8]
Biotinidase (BTD) OTJYTQ69 BTD_HUMAN Decreases Expression [8]
Nicotinamide phosphoribosyltransferase (NAMPT) OTVJR3GL NAMPT_HUMAN Decreases Expression [8]
Solute carrier family 15 member 1 (SLC15A1) OT1P16B5 S15A1_HUMAN Decreases Expression [8]
Radiation-inducible immediate-early gene IEX-1 (IER3) OTZJI5FZ IEX1_HUMAN Decreases Expression [8]
Stromal cell-derived factor 1 (CXCL12) OT2QX5LL SDF1_HUMAN Increases Expression [8]
NADP-dependent malic enzyme (ME1) OTSVEUQE MAOX_HUMAN Decreases Expression [8]
Gamma-aminobutyric acid receptor subunit alpha-4 (GABRA4) OT5I7OI2 GBRA4_HUMAN Decreases Expression [8]
ATP synthase F(0) complex subunit C3, mitochondrial (ATP5MC3) OTX674BU AT5G3_HUMAN Decreases Expression [8]
Glutamate--cysteine ligase regulatory subunit (GCLM) OT6CP234 GSH0_HUMAN Decreases Expression [8]
Adhesion G protein-coupled receptor E5 (ADGRE5) OTTSB84Q AGRE5_HUMAN Increases Expression [8]
Natural resistance-associated macrophage protein 2 (SLC11A2) OTMEUHE8 NRAM2_HUMAN Decreases Expression [8]
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADVL) OT50L4XB ACADV_HUMAN Decreases Expression [8]
Acyl-coenzyme A thioesterase 2, mitochondrial (ACOT2) OTAKUO27 ACOT2_HUMAN Decreases Expression [8]
Fms-related tyrosine kinase 3 ligand (FLT3LG) OTU0YGC4 FLT3L_HUMAN Increases Expression [8]
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 (GNG4) OTOXNDI9 GBG4_HUMAN Decreases Expression [8]
Biotin--protein ligase (HLCS) OTPDUX30 BPL1_HUMAN Decreases Expression [8]
Ras association domain-containing protein 2 (RASSF2) OT2JHDO4 RASF2_HUMAN Increases Expression [8]
Ras-related protein Rab-27A (RAB27A) OT9SQRWY RB27A_HUMAN Decreases Expression [8]
Gastrotropin (FABP6) OTIRQWLW FABP6_HUMAN Decreases Expression [8]
B-cell receptor-associated protein 31 (BCAP31) OTKSACR4 BAP31_HUMAN Decreases Expression [8]
H(+)/Cl(-) exchange transporter 3 (CLCN3) OTEEXNMU CLCN3_HUMAN Decreases Expression [8]
G-protein coupled receptor 143 (GPR143) OTWUA2AV GP143_HUMAN Decreases Expression [8]
6-phosphogluconate dehydrogenase, decarboxylating (PGD) OTVG296F 6PGD_HUMAN Decreases Expression [8]
Rho GDP-dissociation inhibitor 2 (ARHGDIB) OT9PD6CS GDIR2_HUMAN Increases Expression [8]
ATP-citrate synthase (ACLY) OTRL9ZRP ACLY_HUMAN Decreases Expression [8]
Protein FosB (FOSB) OTW6C05J FOSB_HUMAN Decreases Expression [8]
Succinate--CoA ligase subunit alpha, mitochondrial (SUCLG1) OTDCSPXH SUCA_HUMAN Decreases Expression [8]
Diphosphomevalonate decarboxylase (MVD) OTGEX4SR MVD1_HUMAN Decreases Expression [8]
Phospholipid transfer protein (PLTP) OTVJJO5Z PLTP_HUMAN Increases Expression [8]
Microfibril-associated glycoprotein 4 (MFAP4) OT5W64QY MFAP4_HUMAN Increases Expression [8]
ATP synthase subunit f, mitochondrial (ATP5MF) OTE4TBG9 ATPK_HUMAN Decreases Expression [8]
ATP synthase subunit ATP5MJ, mitochondrial (ATP5MJ) OT7B6C6M ATP68_HUMAN Decreases Expression [8]
Peroxisomal biogenesis factor 3 (PEX3) OTGZ7ME2 PEX3_HUMAN Decreases Expression [8]
3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 (HSD17B7) OTV7VOV3 DHB7_HUMAN Decreases Expression [8]
Transmembrane protein 33 (TMEM33) OTRG1DOY TMM33_HUMAN Decreases Expression [8]
Ras-related protein Rab-38 (RAB38) OTU0NZU0 RAB38_HUMAN Decreases Expression [8]
T-cell leukemia translocation-altered gene protein (TCTA) OT0AH12O TCTA_HUMAN Decreases Expression [8]
Histone H2B type 1-D (H2BC5) OTXDTDHN H2B1D_HUMAN Decreases Expression [8]
AP-3 complex subunit sigma-2 (AP3S2) OTN8P9OE AP3S2_HUMAN Decreases Expression [8]
CD81 antigen (CD81) OTQFXNAZ CD81_HUMAN Increases Expression [8]
Signal peptidase complex subunit 3 (SPCS3) OTAPFSUQ SPCS3_HUMAN Decreases Expression [8]
Rho-related GTP-binding protein RhoE (RND3) OTXMXPIH RND3_HUMAN Decreases Expression [8]
Histone H2B type 1-C/E/F/G/I (H2BC10) OTLQH0D6 H2B1C_HUMAN Decreases Expression [8]
AP-2 complex subunit beta (AP2B1) OTL6LZJ4 AP2B1_HUMAN Increases Expression [8]
Tyrosine-protein phosphatase non-receptor type substrate 1 (SIRPA) OT2CEYTT SHPS1_HUMAN Increases Expression [8]
Cytochrome P450 4F2 (CYP4F2) OTKILAER CP4F2_HUMAN Decreases Expression [8]
UDP-galactose translocator (SLC35A2) OTQOTOWZ S35A2_HUMAN Decreases Expression [8]
Solute carrier family 35 member B1 (SLC35B1) OTJ1MRN2 S35B1_HUMAN Decreases Expression [8]
Arginase-2, mitochondrial (ARG2) OTCPI0E8 ARGI2_HUMAN Decreases Expression [8]
Interleukin-13 receptor subunit alpha-1 (IL13RA1) OT59OYXP I13R1_HUMAN Decreases Expression [8]
Interferon-induced 35 kDa protein (IFI35) OTV9RZ53 IN35_HUMAN Increases Expression [8]
Brain acid soluble protein 1 (BASP1) OTF4VS5G BASP1_HUMAN Increases Expression [8]
Cytochrome P450 4F8 (CYP4F8) OT437NB2 CP4F8_HUMAN Decreases Expression [8]
Cyclin-dependent kinase 5 (CDK5) OT1YAK9F CDK5_HUMAN Decreases Expression [8]
Sorbitol dehydrogenase (SORD) OTC44CR6 DHSO_HUMAN Decreases Expression [8]
Ankyrin-2 (ANK2) OTWB4R1Y ANK2_HUMAN Increases Expression [8]
Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMGCS1) OTCO26FV HMCS1_HUMAN Decreases Expression [8]
Large neutral amino acids transporter small subunit 1 (SLC7A5) OT2WPVXD LAT1_HUMAN Decreases Expression [8]
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1) OTEUYEW6 ROR1_HUMAN Increases Expression [8]
D-beta-hydroxybutyrate dehydrogenase, mitochondrial (BDH1) OT62RL5P BDH_HUMAN Decreases Expression [8]
Desmocollin-2 (DSC2) OTODVH8K DSC2_HUMAN Decreases Expression [8]
Mitochondrial 2-oxoglutarate/malate carrier protein (SLC25A11) OT7EVFBK M2OM_HUMAN Decreases Expression [8]
Aminoacylase-1 (ACY1) OT9WU7X3 ACY1_HUMAN Decreases Expression [8]
6-pyruvoyl tetrahydrobiopterin synthase (PTS) OTTYWQXR PTPS_HUMAN Decreases Expression [8]
Trefoil factor 2 (TFF2) OTRXB19X TFF2_HUMAN Decreases Expression [8]
Mevalonate kinase (MVK) OTHJCUKT KIME_HUMAN Decreases Expression [8]
1,4-alpha-glucan-branching enzyme (GBE1) OTK2N05B GLGB_HUMAN Decreases Expression [8]
Dynamin-1 (DNM1) OTI8X2WQ DYN1_HUMAN Increases Expression [8]
Caldesmon (CALD1) OTNJKJ6Q CALD1_HUMAN Increases Expression [8]
Collagen alpha-1(XIV) chain (COL14A1) OTLNJ13O COEA1_HUMAN Increases Expression [8]
Myocyte-specific enhancer factor 2C (MEF2C) OTZGF1Y5 MEF2C_HUMAN Increases Expression [8]
Early growth response protein 3 (EGR3) OTGPJIRA EGR3_HUMAN Decreases Expression [8]
Cytochrome P450 4F3 (CYP4F3) OTYNSQAM CP4F3_HUMAN Decreases Expression [8]
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (ECH1) OTA0UNHM ECH1_HUMAN Decreases Expression [8]
G antigen 5 (GAGE5) OTFI6OVS GAGE5_HUMAN Decreases Expression [8]
Acetyl-CoA carboxylase 1 (ACACA) OT5CQPZY ACACA_HUMAN Decreases Expression [8]
Platelet-activating factor acetylhydrolase (PLA2G7) OT6H6AMO PAFA_HUMAN Decreases Expression [8]
Lymphocyte cytosolic protein 2 (LCP2) OT57KE22 LCP2_HUMAN Increases Expression [8]
Dual specificity protein phosphatase 4 (DUSP4) OT6WAO12 DUS4_HUMAN Decreases Expression [8]
DnaJ homolog subfamily C member 3 (DNAJC3) OT7ROIJF DNJC3_HUMAN Decreases Expression [8]
Src-like-adapter (SLA) OTV17DY2 SLAP1_HUMAN Increases Expression [8]
Frizzled-5 (FZD5) OTXFFY56 FZD5_HUMAN Decreases Expression [8]
Dystrophin-related protein 2 (DRP2) OTWR7WGU DRP2_HUMAN Decreases Expression [8]
Metaxin-1 (MTX1) OTLSDNZO MTX1_HUMAN Decreases Expression [8]
Lysosomal-associated transmembrane protein 5 (LAPTM5) OT2XI2JG LAPM5_HUMAN Increases Expression [8]
CD166 antigen (ALCAM) OTCO4LP7 CD166_HUMAN Decreases Expression [8]
Plakophilin-1 (PKP1) OT9HSQ8F PKP1_HUMAN Increases Expression [8]
Isopentenyl-diphosphate Delta-isomerase 1 (IDI1) OTGM06VJ IDI1_HUMAN Decreases Expression [8]
Protein Tob2 (TOB2) OTEEHL60 TOB2_HUMAN Increases Expression [8]
Transcription factor Dp-2 (TFDP2) OTKQFX5H TFDP2_HUMAN Decreases Expression [8]
P-selectin glycoprotein ligand 1 (SELPLG) OTOK3301 SELPL_HUMAN Increases Expression [8]
Src substrate cortactin (CTTN) OTJRG4ES SRC8_HUMAN Decreases Expression [8]
EKC/KEOPS complex subunit LAGE3 (LAGE3) OTKBQHZI LAGE3_HUMAN Decreases Expression [8]
DNA replication complex GINS protein PSF1 (GINS1) OTVQZMMQ PSF1_HUMAN Decreases Expression [8]
Phosphatidate phosphatase LPIN1 (LPIN1) OTQ75KF2 LPIN1_HUMAN Decreases Expression [8]
Latent-transforming growth factor beta-binding protein 1 (LTBP1) OTR7Q75L LTBP1_HUMAN Increases Expression [8]
Metal cation symporter ZIP14 (SLC39A14) OTGR686L S39AE_HUMAN Increases Expression [8]
Rho guanine nucleotide exchange factor 6 (ARHGEF6) OTN1ABGL ARHG6_HUMAN Increases Expression [8]
Procollagen C-endopeptidase enhancer 1 (PCOLCE) OTJXOAN4 PCOC1_HUMAN Increases Expression [8]
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EBP) OTSMGKXQ EBP_HUMAN Decreases Expression [8]
Phosphomevalonate kinase (PMVK) OTPBR06U PMVK_HUMAN Decreases Expression [8]
Serum paraoxonase/lactonase 3 (PON3) OT80W9TA PON3_HUMAN Decreases Expression [8]
Delta(24)-sterol reductase (DHCR24) OTP301JW DHC24_HUMAN Decreases Expression [8]
Dixin (DIXDC1) OT87DXEG DIXC1_HUMAN Increases Expression [8]
Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (NSDHL) OTK3EJFD NSDHL_HUMAN Decreases Expression [8]
Chitinase-3-like protein 2 (CHI3L2) OT26R3HQ CH3L2_HUMAN Decreases Expression [8]
Methylsterol monooxygenase 1 (MSMO1) OTKV62RZ MSMO1_HUMAN Decreases Expression [8]
Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETFDH) OTOSKSFH ETFD_HUMAN Decreases Expression [8]
Dihydropyrimidinase-related protein 2 (DPYSL2) OTWNQ74H DPYL2_HUMAN Increases Expression [8]
BDNF/NT-3 growth factors receptor (NTRK2) OTD557PU NTRK2_HUMAN Increases Expression [8]
Drebrin (DBN1) OTZVKG8A DREB_HUMAN Increases Expression [8]
Prostasin (PRSS8) OT5KLL35 PRSS8_HUMAN Decreases Expression [8]
Melanoma antigen recognized by T-cells 1 (MLANA) OT1N2S2K MAR1_HUMAN Decreases Expression [8]
Forkhead box protein D1 (FOXD1) OT80PRHS FOXD1_HUMAN Increases Expression [8]
Thiosulfate sulfurtransferase (TST) OTZ4F5LK THTR_HUMAN Decreases Expression [8]
Histone H2B type 2-E (H2BC21) OT0FDCUC H2B2E_HUMAN Decreases Expression [8]
Reticulon-1 (RTN1) OTCX1SMK RTN1_HUMAN Increases Expression [8]
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HADH) OTJDOL20 HCDH_HUMAN Decreases Expression [8]
Lanosterol 14-alpha demethylase (CYP51A1) OTAYHG9C CP51A_HUMAN Decreases Expression [8]
Tumor protein D53 (TPD52L1) OTSA6U0I TPD53_HUMAN Decreases Expression [8]
Protein BEAN1 (BEAN1) OT0WLH27 BEAN1_HUMAN Decreases Expression [8]
Prolyl endopeptidase-like (PREPL) OTN5XMLZ PPCEL_HUMAN Decreases Expression [8]
ORM1-like protein 2 (ORMDL2) OT2N1MW0 ORML2_HUMAN Decreases Expression [8]
Pleckstrin homology-like domain family A member 2 (PHLDA2) OTMV9DPP PHLA2_HUMAN Decreases Expression [8]
Very-long-chain 3-oxoacyl-CoA reductase (HSD17B12) OTW95XD4 DHB12_HUMAN Decreases Expression [8]
Endoribonuclease LACTB2 (LACTB2) OTU4IFBU LACB2_HUMAN Decreases Expression [8]
Transmembrane protein 41B (TMEM41B) OTW0B0KS TM41B_HUMAN Decreases Expression [8]
Sigma intracellular receptor 2 (TMEM97) OTH76ZWK SGMR2_HUMAN Decreases Expression [8]
Protein odr-4 homolog (ODR4) OTGC56W3 ODR4_HUMAN Decreases Expression [8]
Na(+)/H(+) exchange regulatory cofactor NHE-RF3 (PDZK1) OTGFK4MH NHRF3_HUMAN Decreases Expression [8]
Transmembrane protein 164 (TMEM164) OTSIZY2T TM164_HUMAN Decreases Expression [8]
Terminal nucleotidyltransferase 5C (TENT5C) OTOWVQ4O TET5C_HUMAN Decreases Expression [8]
KN motif and ankyrin repeat domain-containing protein 2 (KANK2) OT3SZIWM KANK2_HUMAN Increases Expression [8]
Dehydrogenase/reductase SDR family member 7B (DHRS7B) OTO2YA2O DRS7B_HUMAN Decreases Expression [8]
Desumoylating isopeptidase 1 (DESI1) OTFNIW98 DESI1_HUMAN Decreases Expression [8]
DENN domain-containing protein 5A (DENND5A) OT0QNNY1 DEN5A_HUMAN Increases Expression [8]
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (HIBCH) OTU2VHWR HIBCH_HUMAN Decreases Expression [8]
Caveolae-associated protein 1 (CAVIN1) OTFO915U CAVN1_HUMAN Increases Expression [8]
Lysophospholipid acyltransferase 5 (LPCAT3) OTWI96P4 MBOA5_HUMAN Decreases Expression [8]
Transmembrane protein 53 (TMEM53) OTSXTGQK TMM53_HUMAN Decreases Expression [8]
Progestin and adipoQ receptor family member 3 (PAQR3) OTTKJ9Y4 PAQR3_HUMAN Decreases Expression [8]
CREB-regulated transcription coactivator 3 (CRTC3) OTVIGVUW CRTC3_HUMAN Increases Expression [8]
Dehydrogenase/reductase SDR family member 11 (DHRS11) OTU3J0ZL DHR11_HUMAN Decreases Expression [8]
MICOS complex subunit MIC27 (APOOL) OTC1WT8O MIC27_HUMAN Decreases Expression [8]
Calcium/manganese antiporter SLC30A10 (SLC30A10) OTXM5JW4 ZNT10_HUMAN Decreases Expression [8]
Solute carrier organic anion transporter family member 4C1 (SLCO4C1) OTVILUUN SO4C1_HUMAN Decreases Expression [8]
Lysophospholipid acyltransferase 2 (MBOAT2) OTZI3BXD MBOA2_HUMAN Decreases Expression [8]
La-related protein 4 (LARP4) OTB10IJH LARP4_HUMAN Decreases Expression [8]
BEN domain-containing protein 5 (BEND5) OT6J6LY3 BEND5_HUMAN Increases Expression [8]
Fatty acid 2-hydroxylase (FA2H) OT8HA13U FA2H_HUMAN Decreases Expression [8]
Histone H2A type 3 (H2AC25) OTPO62JI H2A3_HUMAN Decreases Expression [8]
Lysosomal proton-coupled steroid conjugate and bile acid symporter SLC46A3 (SLC46A3) OTEMDLPS S46A3_HUMAN Decreases Expression [8]
L-xylulose reductase (DCXR) OTYVXRXB DCXR_HUMAN Decreases Expression [8]
Sprouty-related, EVH1 domain-containing protein 2 (SPRED2) OTUX685J SPRE2_HUMAN Increases Expression [8]
Glutaredoxin-related protein 5, mitochondrial (GLRX5) OTE3L48D GLRX5_HUMAN Decreases Expression [8]
TBC1 domain family member 1 (TBC1D1) OTI9V7B0 TBCD1_HUMAN Increases Expression [8]
Acetoacetyl-CoA synthetase (AACS) OTGGPR6J AACS_HUMAN Decreases Expression [8]
Ribosomal oxygenase 2 (RIOX2) OT2YFPI2 RIOX2_HUMAN Decreases Expression [8]
Malonyl-CoA-acyl carrier protein transacylase, mitochondrial (MCAT) OTH07FIW FABD_HUMAN Decreases Expression [8]
Ankyrin repeat and KH domain-containing protein 1 (ANKHD1) OTVYQ7ZL ANKH1_HUMAN Decreases Expression [8]
Intraflagellar transport protein 20 homolog (IFT20) OTKJS2BZ IFT20_HUMAN Decreases Expression [8]
Adhesion G-protein coupled receptor G2 (ADGRG2) OTPAD5S1 AGRG2_HUMAN Decreases Expression [8]
Multiple coagulation factor deficiency protein 2 (MCFD2) OTM0XU0U MCFD2_HUMAN Decreases Expression [8]
Kelch domain-containing protein 4 (KLHDC4) OTJ4UL5S KLDC4_HUMAN Decreases Expression [8]
Transmembrane protein 254 (TMEM254) OTGDPU8S TM254_HUMAN Decreases Expression [8]
Retinol dehydrogenase 11 (RDH11) OTIND43N RDH11_HUMAN Decreases Expression [8]
Disks large homolog 5 (DLG5) OTU9Z17K DLG5_HUMAN Increases Expression [8]
Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 (ASAP3) OTQB4H1J ASAP3_HUMAN Increases Expression [8]
E3 ubiquitin-protein ligase RNF128 (RNF128) OTJO86CJ RN128_HUMAN Decreases Expression [8]
Sushi, nidogen and EGF-like domain-containing protein 1 (SNED1) OTBQVXY5 SNED1_HUMAN Increases Expression [8]
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 (ABHD5) OTY829Z3 ABHD5_HUMAN Decreases Expression [8]
Cysteine protease ATG4A (ATG4A) OTDHXAPG ATG4A_HUMAN Decreases Expression [8]
Protein FAM3C (FAM3C) OTBR6U9G FAM3C_HUMAN Decreases Expression [8]
Serine protease HTRA1 (HTRA1) OTR8ACBF HTRA1_HUMAN Increases Expression [8]
Synapsin-2 (SYN2) OTK0DEGH SYN2_HUMAN Decreases Expression [8]
Deoxyribonuclease-1-like 2 (DNASE1L2) OT56VFRL DNSL2_HUMAN Decreases Expression [8]
Peroxisomal membrane protein PEX13 (PEX13) OTXUAYEW PEX13_HUMAN Decreases Expression [8]
RNA-binding protein with multiple splicing (RBPMS) OT1RDKR9 RBPMS_HUMAN Increases Expression [8]
Histone H2B type 1-H (H2BC9) OTQ9XX72 H2B1H_HUMAN Decreases Expression [8]
Homogentisate 1,2-dioxygenase (HGD) OTTKLQOO HGD_HUMAN Decreases Expression [8]
Riboflavin kinase (RFK) OT77IYIS RIFK_HUMAN Decreases Expression [8]
Protein N-terminal asparagine amidohydrolase (NTAN1) OTJF0U48 NTAN1_HUMAN Decreases Expression [8]
Mitochondrial calcium uniporter regulator 1 (MCUR1) OTSL49SR MCUR1_HUMAN Decreases Expression [8]
Peptidyl-prolyl cis-trans isomerase FKBP10 (FKBP10) OTYKLW1K FKB10_HUMAN Increases Expression [8]
Solute carrier family 22 member 18 (SLC22A18) OT9C3KR4 S22AI_HUMAN Decreases Expression [8]
Isochorismatase domain-containing protein 1 (ISOC1) OTAO7Z87 ISOC1_HUMAN Decreases Expression [8]
BTB/POZ domain-containing protein KCTD12 (KCTD12) OTPYKT4Z KCD12_HUMAN Increases Expression [8]
Regulator of microtubule dynamics protein 1 (RMDN1) OTE1NB6U RMD1_HUMAN Decreases Expression [8]
Ubiquitin thioesterase OTUB2 (OTUB2) OTZUMPH2 OTUB2_HUMAN Decreases Expression [8]
Molybdenum cofactor sulfurase (MOCOS) OT0TL3Q5 MOCOS_HUMAN Decreases Expression [8]
DnaJ homolog subfamily A member 3, mitochondrial (DNAJA3) OT61924T DNJA3_HUMAN Decreases Expression [8]
Mediator of RNA polymerase II transcription subunit 8 (MED8) OTSIZ1I7 MED8_HUMAN Decreases Expression [8]
Long-chain-fatty-acid--CoA ligase ACSBG1 (ACSBG1) OTM040MW ACBG1_HUMAN Decreases Expression [8]
PRKC apoptosis WT1 regulator protein (PAWR) OTKY7W52 PAWR_HUMAN Decreases Expression [8]
Androgen-dependent TFPI-regulating protein (ADTRP) OTFI2BQX ADTRP_HUMAN Decreases Expression [8]
Fatty acyl-CoA reductase 2 (FAR2) OTRYY709 FACR2_HUMAN Decreases Expression [8]
Cytosolic non-specific dipeptidase (CNDP2) OTJR9436 CNDP2_HUMAN Decreases Expression [8]
bMERB domain-containing protein 1 (BMERB1) OT1IH086 MERB1_HUMAN Increases Expression [8]
Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1L1) OT9IEBRD GD1L1_HUMAN Decreases Expression [8]
Adhesion G protein-coupled receptor A2 (ADGRA2) OTBT4W36 AGRA2_HUMAN Increases Expression [8]
KH domain-containing RNA-binding protein QKI (QKI) OTTAUGLB QKI_HUMAN Increases Expression [8]
Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCC1) OTLOHEQE MCCA_HUMAN Decreases Expression [8]
Mitochondrial tRNA methylthiotransferase CDK5RAP1 (CDK5RAP1) OTDEJXD0 CK5P1_HUMAN Decreases Expression [8]
Protein phosphatase 1 regulatory inhibitor subunit 16B (PPP1R16B) OTZJFX5C PP16B_HUMAN Increases Expression [8]
c-Myc-binding protein (MYCBP) OT4IZR4R MYCBP_HUMAN Decreases Expression [8]
Peroxisomal acyl-coenzyme A oxidase 2 (ACOX2) OT3VH359 ACOX2_HUMAN Decreases Expression [8]
V-type proton ATPase 21 kDa proteolipid subunit c'' (ATP6V0B) OT8GTI1V VATO_HUMAN Decreases Expression [8]
Platelet-activating factor acetylhydrolase 2, cytoplasmic (PAFAH2) OTSHD5M5 PAFA2_HUMAN Decreases Expression [8]
D-aspartate oxidase (DDO) OT6JU3I9 OXDD_HUMAN Decreases Expression [8]
Sortilin (SORT1) OTFCQ4B1 SORT_HUMAN Decreases Expression [8]
Perilipin-2 (PLIN2) OTRXJ9UN PLIN2_HUMAN Decreases Expression [8]
Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (SDHC) OTC8G2MX C560_HUMAN Decreases Expression [8]
Calcineurin B homologous protein 1 (CHP1) OTHTXN1A CHP1_HUMAN Decreases Expression [8]
ATP-sensitive inward rectifier potassium channel 15 (KCNJ15) OTZT6EQB KCJ15_HUMAN Decreases Expression [8]
Dehydrogenase/reductase SDR family member 9 (DHRS9) OTB1WOZA DHRS9_HUMAN Decreases Expression [8]
Calsyntenin-3 (CLSTN3) OTPUFK4C CSTN3_HUMAN Decreases Expression [8]
Sugar transporter SWEET1 (SLC50A1) OTF1DT72 SWET1_HUMAN Decreases Expression [8]
Transmembrane protein 208 (TMEM208) OTMGH9OA TM208_HUMAN Decreases Expression [8]
Iron-sulfur cluster assembly 1 homolog, mitochondrial (ISCA1) OTU230MC ISCA1_HUMAN Decreases Expression [8]
GEL complex subunit OPTI (RAB5IF) OTNNWX7E RCAF1_HUMAN Decreases Expression [8]
Bublin coiled-coil protein (BBLN) OTUMVEWE BBLN_HUMAN Decreases Expression [8]
Enoyl- reductase, mitochondrial (MECR) OTJQ5XKQ MECR_HUMAN Decreases Expression [8]
Very long chain fatty acid elongase 1 (ELOVL1) OTIDTQ8R ELOV1_HUMAN Decreases Expression [8]
Acetyl-CoA acetyltransferase, cytosolic (ACAT2) OTZ092ZJ THIC_HUMAN Decreases Expression [8]
Sorbin and SH3 domain-containing protein 1 (SORBS1) OTWH8762 SRBS1_HUMAN Decreases Expression [8]
N-acetylneuraminate lyase (NPL) OTA7P0TO NPL_HUMAN Decreases Expression [8]
Peroxisomal trans-2-enoyl-CoA reductase (PECR) OT5MS8EM PECR_HUMAN Decreases Expression [8]
Alpha-(1,6)-fucosyltransferase (FUT8) OTJJCVG1 FUT8_HUMAN Increases Expression [8]
F-box-like/WD repeat-containing protein TBL1XR1 (TBL1XR1) OTM3B3OA TBL1R_HUMAN Increases Expression [8]
Metal cation symporter ZIP8 (SLC39A8) OT6C6MNV S39A8_HUMAN Decreases Expression [8]
Very long chain fatty acid elongase 4 (ELOVL4) OT2M9W26 ELOV4_HUMAN Decreases Expression [8]
Superkiller complex protein 8 (SKIC8) OTDSQYDN SKI8_HUMAN Decreases Expression [8]
Carbohydrate sulfotransferase 6 (CHST6) OTXD2IWK CHST6_HUMAN Increases Expression [8]
E3 ubiquitin-protein ligase RNF38 (RNF38) OTRLV4WZ RNF38_HUMAN Increases Expression [8]
Uncharacterized protein C1orf21 (C1ORF21) OTMD7O88 CA021_HUMAN Increases Expression [8]
Growth hormone-inducible transmembrane protein (GHITM) OTBPNIC0 GHITM_HUMAN Decreases Expression [8]
Ribokinase (RBKS) OTDG01Y9 RBSK_HUMAN Decreases Expression [8]
Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase (ST6GALNAC4) OTJCJQI7 SIA7D_HUMAN Decreases Expression [8]
Serine hydrolase-like protein 2 (SERHL2) OTVM8TVT SEHL2_HUMAN Increases Expression [8]
Coiled-coil domain-containing protein 86 (CCDC86) OT5YQ0R0 CCD86_HUMAN Decreases Expression [8]
Reticulophagy regulator 1 (RETREG1) OTYOSLZX RETR1_HUMAN Decreases Expression [8]
Histone-lysine N-methyltransferase SMYD3 (SMYD3) OT9YR20G SMYD3_HUMAN Increases Expression [8]
Pantothenate kinase 3 (PANK3) OT77CFJ6 PANK3_HUMAN Decreases Expression [8]
Ceramide synthase 4 (CERS4) OTV5ENAX CERS4_HUMAN Decreases Expression [8]
GrpE protein homolog 1, mitochondrial (GRPEL1) OT8O00YJ GRPE1_HUMAN Decreases Expression [8]
Roquin-2 (RC3H2) OTZR3GF6 RC3H2_HUMAN Decreases Expression [8]
Ethanolamine kinase 1 (ETNK1) OTDKB4DQ EKI1_HUMAN Decreases Expression [8]
Popeye domain-containing protein 2 (POPDC2) OTDAZSY5 POPD2_HUMAN Decreases Expression [8]
Serine/threonine-protein kinase Sgk2 (SGK2) OTCTVSHF SGK2_HUMAN Decreases Expression [8]
Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCC2) OTQDHSMI MCCB_HUMAN Decreases Expression [8]
Stromal cell-derived factor 2-like protein 1 (SDF2L1) OTE7JIO2 SDF2L_HUMAN Decreases Expression [8]
Magnesium transporter MRS2 homolog, mitochondrial (MRS2) OTICD11V MRS2_HUMAN Decreases Expression [8]
Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 (ALG13) OTOH9PMY ALG13_HUMAN Decreases Expression [8]
Lysophosphatidic acid phosphatase type 6 (ACP6) OTPW6HEK PPA6_HUMAN Decreases Expression [8]
Acyl-coenzyme A thioesterase 13 (ACOT13) OTWRUST1 ACO13_HUMAN Decreases Expression [8]
Omega-amidase NIT2 (NIT2) OTC1RAH3 NIT2_HUMAN Decreases Expression [8]
Translation initiation factor eIF2B subunit gamma (EIF2B3) OTG6HE7D EI2BG_HUMAN Decreases Expression [8]
Peroxisomal membrane protein 2 (PXMP2) OTYHX5MI PXMP2_HUMAN Decreases Expression [8]
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (AGPAT3) OTAUR5TG PLCC_HUMAN Decreases Expression [8]
Glutaredoxin-2, mitochondrial (GLRX2) OT4LIRBC GLRX2_HUMAN Decreases Expression [8]
SAM domain-containing protein SAMSN-1 (SAMSN1) OT7N88T1 SAMN1_HUMAN Increases Expression [8]
1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 (PNPLA3) OTR4990X PLPL3_HUMAN Decreases Expression [8]
Ethylmalonyl-CoA decarboxylase (ECHDC1) OTMS00PY ECHD1_HUMAN Decreases Expression [8]
S-acyl fatty acid synthase thioesterase, medium chain (OLAH) OTZVRM40 SAST_HUMAN Decreases Expression [8]
Septin-11 (SEPTIN11) OTX2O0ZX SEP11_HUMAN Decreases Expression [8]
Large ribosomal subunit protein mL66 (MRPS18A) OTFCBPX2 RT18A_HUMAN Decreases Expression [8]
Anoctamin-10 (ANO10) OTG3BNOU ANO10_HUMAN Decreases Expression [8]
Dipeptidyl peptidase 3 (DPP3) OTUIVL1C DPP3_HUMAN Decreases Expression [8]
Very long chain fatty acid elongase 5 (ELOVL5) OT375W1Z ELOV5_HUMAN Decreases Expression [8]
2-Hydroxyacid oxidase 2 (HAO2) OTDWSQ0L HAOX2_HUMAN Decreases Expression [8]
Very-long-chain enoyl-CoA reductase (TECR) OT2NT4MV TECR_HUMAN Decreases Expression [8]
Alpha-hemoglobin-stabilizing protein (AHSP) OTTHBSUS AHSP_HUMAN Decreases Expression [8]
Adenosine deaminase 2 (ADA2) OTGCV24S ADA2_HUMAN Increases Expression [8]
Methionine-R-sulfoxide reductase B1 (MSRB1) OTLLNIMF MSRB1_HUMAN Decreases Expression [8]
Cysteine-rich PDZ-binding protein (CRIPT) OTA6M8M4 CRIPT_HUMAN Decreases Expression [8]
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 (HCN3) OTMO1ZYQ HCN3_HUMAN Decreases Expression [8]
7-dehydrocholesterol reductase (DHCR7) OTLILBUI DHCR7_HUMAN Decreases Expression [8]
Signal-transducing adaptor protein 2 (STAP2) OTEB1VVI STAP2_HUMAN Decreases Expression [8]
Alpha-methylacyl-CoA racemase (AMACR) OTUU22PK AMACR_HUMAN Decreases Expression [8]
B-cell receptor-associated protein 29 (BCAP29) OTLUBG86 BAP29_HUMAN Decreases Expression [8]
Fasciculation and elongation protein zeta-2 (FEZ2) OTAFCKAX FEZ2_HUMAN Increases Expression [8]
Transgelin-3 (TAGLN3) OTJBP3VJ TAGL3_HUMAN Decreases Expression [8]
Motile sperm domain-containing protein 1 (MOSPD1) OT993HTH MSPD1_HUMAN Decreases Expression [8]
F-box/LRR-repeat protein 7 (FBXL7) OTNUK1DJ FBXL7_HUMAN Increases Expression [8]
F-box only protein 9 (FBXO9) OTW5P5JF FBX9_HUMAN Decreases Expression [8]
A-kinase anchor protein 11 (AKAP11) OT7E2FVD AKA11_HUMAN Increases Expression [8]
Phosphatidylcholine transfer protein (PCTP) OTM36JXE PPCT_HUMAN Decreases Expression [8]
Ergosterol biosynthetic protein 28 homolog (ERG28) OT2KAOBA ERG28_HUMAN Decreases Expression [8]
Isobutyryl-CoA dehydrogenase, mitochondrial (ACAD8) OT3JI5GB ACAD8_HUMAN Decreases Expression [8]
Cilia- and flagella-associated protein 45 (CFAP45) OT8I8ZHH CFA45_HUMAN Decreases Expression [8]
Transmembrane protease serine 11E (TMPRSS11E) OTO5U2TK TM11E_HUMAN Decreases Expression [8]
Malignant T-cell-amplified sequence 1 (MCTS1) OT7SAOJP MCTS1_HUMAN Decreases Expression [8]
Long-chain-fatty-acid--CoA ligase 5 (ACSL5) OT3L9XO3 ACSL5_HUMAN Decreases Expression [8]
Myocardin-related transcription factor B (MRTFB) OT9OXGS9 MRTFB_HUMAN Increases Expression [8]
Transcription factor MafF (MAFF) OT9B7MX0 MAFF_HUMAN Decreases Expression [8]
LIM and calponin homology domains-containing protein 1 (LIMCH1) OTYPC4XA LIMC1_HUMAN Increases Expression [8]
Inactive phospholipase C-like protein 2 (PLCL2) OTK5FDF6 PLCL2_HUMAN Increases Expression [8]
Tenascin-N (TNN) OTQK2AMX TENN_HUMAN Increases Expression [8]
TRAF3-interacting JNK-activating modulator (TRAF3IP3) OTNG0L8X T3JAM_HUMAN Increases Expression [8]
Sodium-dependent multivitamin transporter (SLC5A6) OT77CX29 SC5A6_HUMAN Decreases Expression [8]
Small ribosomal subunit protein mS33 (MRPS33) OTM44AZ1 RT33_HUMAN Decreases Expression [8]
BTB/POZ domain-containing protein 3 (BTBD3) OTZ607YT BTBD3_HUMAN Increases Expression [8]
Protein MTO1 homolog, mitochondrial (MTO1) OT7HCZ1D MTO1_HUMAN Decreases Expression [8]
Transmembrane emp24 domain-containing protein 5 (TMED5) OT70W1J8 TMED5_HUMAN Decreases Expression [8]
Nucleolar protein 16 (NOP16) OT2829ZC NOP16_HUMAN Decreases Expression [8]
Small ribosomal subunit protein bS16m (MRPS16) OT3XXKDZ RT16_HUMAN Decreases Expression [8]
Peptidyl-tRNA hydrolase 2, mitochondrial (PTRH2) OTBU39Q1 PTH2_HUMAN Decreases Expression [8]
Protein dopey-2 (DOP1B) OTQTOWLQ DOP2_HUMAN Decreases Expression [8]
Lysyl oxidase homolog 2 (LOXL2) OTRT46B5 LOXL2_HUMAN Increases Expression [8]
Sorting and assembly machinery component 50 homolog (SAMM50) OTRYFYIU SAM50_HUMAN Decreases Expression [8]
V-type proton ATPase subunit D (ATP6V1D) OT4JDG0W VATD_HUMAN Decreases Expression [8]
Hypoxia-inducible lipid droplet-associated protein (HILPDA) OTEID3ZM HLPDA_HUMAN Decreases Expression [8]
Mitochondrial import inner membrane translocase subunit Tim13 (TIMM13) OTYZQJD3 TIM13_HUMAN Decreases Expression [8]
DnaJ homolog subfamily C member 15 (DNAJC15) OTNDUKAA DJC15_HUMAN Decreases Expression [8]
Mitochondrial pyruvate carrier 1 (MPC1) OT6DYFUO MPC1_HUMAN Decreases Expression [8]
Sorting nexin-13 (SNX13) OTB7IB7X SNX13_HUMAN Decreases Expression [8]
Peroxisomal membrane protein PEX16 (PEX16) OTJQJ2TZ PEX16_HUMAN Decreases Expression [8]
Mitochondrial ornithine transporter 1 (SLC25A15) OTOA9232 ORNT1_HUMAN Decreases Expression [8]
LHFPL tetraspan subfamily member 6 protein (LHFPL6) OTY6LHJY LHPL6_HUMAN Increases Expression [8]
GTP-binding protein SAR1b (SAR1B) OT0JZOMY SAR1B_HUMAN Decreases Expression [8]
Mitochondrial carrier homolog 2 (MTCH2) OTV3E4GU MTCH2_HUMAN Decreases Expression [8]
Peroxisomal membrane protein 4 (PXMP4) OTNDYSHU PXMP4_HUMAN Decreases Expression [8]
Proton-coupled zinc antiporter SLC30A1 (SLC30A1) OTY8J0S4 ZNT1_HUMAN Decreases Expression [8]
Baculoviral IAP repeat-containing protein 5 (BIRC5) OTILXZYL BIRC5_HUMAN Decreases Expression [16]
Nuclear receptor subfamily 1 group I member 2 (NR1I2) OTC5U0N5 NR1I2_HUMAN Increases Activity [17]
Retinal dehydrogenase 2 (ALDH1A2) OTJB560Z AL1A2_HUMAN Decreases Expression [9]
C-X-C motif chemokine 10 (CXCL10) OTTLQ6S0 CXL10_HUMAN Decreases Expression [18]
Interleukin-6 (IL6) OTUOSCCU IL6_HUMAN Decreases Expression [19]
Creatine kinase M-type (CKM) OTME0KO7 KCRM_HUMAN Increases Expression [20]
Retinoic acid receptor alpha (RARA) OT192V9V RARA_HUMAN Increases Expression [21]
Apoptosis regulator Bcl-2 (BCL2) OT9DVHC0 BCL2_HUMAN Increases Expression [22]
C-C motif chemokine 5 (CCL5) OTSCA5CK CCL5_HUMAN Decreases Expression [18]
Hepatocyte growth factor (HGF) OTGHUA23 HGF_HUMAN Decreases Expression [23]
Matrix metalloproteinase-9 (MMP9) OTB2QDAV MMP9_HUMAN Decreases Expression [24]
Cyclic AMP-responsive element-binding protein 1 (CREB1) OT1MDLA1 CREB1_HUMAN Increases Phosphorylation [25]
Glutathione peroxidase 2 (GPX2) OTXI2NTI GPX2_HUMAN Increases Expression [26]
Retinoic acid receptor RXR-alpha (RXRA) OTP1TBDM RXRA_HUMAN Increases Activity [27]
G1/S-specific cyclin-D1 (CCND1) OT8HPTKJ CCND1_HUMAN Decreases Expression [28]
Paired box protein Pax-6 (PAX6) OTOC9876 PAX6_HUMAN Increases Expression [9]
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38) OTG0TTX7 CD38_HUMAN Increases Expression [29]
Caspase-3 (CASP3) OTIJRBE7 CASP3_HUMAN Increases Cleavage [16]
Collagenase 3 (MMP13) OTY8BZIE MMP13_HUMAN Decreases Expression [24]
Retinoic acid receptor responder protein 1 (RARRES1) OTETUPP5 TIG1_HUMAN Increases Expression [28]
Homeobox protein MOX-1 (MEOX1) OTJEMT2D MEOX1_HUMAN Decreases Expression [9]
Transgelin (TAGLN) OTAEZ0KP TAGL_HUMAN Increases Expression [30]
Apoptosis regulator BAX (BAX) OTAW0V4V BAX_HUMAN Increases Expression [31]
Bcl-2-like protein 1 (BCL2L1) OTRC5K9O B2CL1_HUMAN Increases Expression [22]
Mesoderm posterior protein 2 (MESP2) OT7H4LYA MESP2_HUMAN Decreases Expression [9]
Transcription factor 15 (TCF15) OTA6UCWC TCF15_HUMAN Decreases Expression [9]
Caspase-8 (CASP8) OTA8TVI8 CASP8_HUMAN Increases Cleavage [16]
Sonic hedgehog protein (SHH) OTOG2BXF SHH_HUMAN Increases Expression [32]
Oligodendrocyte transcription factor 3 (OLIG3) OTU8XLAF OLIG3_HUMAN Increases Expression [9]
Eyes absent homolog 1 (EYA1) OTHU807A EYA1_HUMAN Decreases Expression [9]
Forkhead box protein C2 (FOXC2) OT83P1E0 FOXC2_HUMAN Decreases Expression [9]
Neurogenin-2 (NEUROG2) OTAEMIGT NGN2_HUMAN Increases Expression [9]
Transcription factor SOX-17 (SOX17) OT9H4WWE SOX17_HUMAN Decreases Localization [33]
Low density lipoprotein (LDLR) OTEZ79V2 E1B4S5_HUMAN Increases ADR [34]
Apolipoprotein E (APOE) OTFOWL2H APOE_HUMAN Affects Response To Substance [35]
Apolipoprotein B-100 (APOB) OTH0UOCZ APOB_HUMAN Increases ADR [34]
Vigilin (HDLBP) OTKDEEYX VIGLN_HUMAN Increases ADR [34]
Glutathione S-transferase P (GSTP1) OTLP0A0Y GSTP1_HUMAN Affects Metabolism [36]
Aquaporin PIP1-2 (PIP1-2) OTN8LSSF PIP12_ARATH Increases ADR [34]
------------------------------------------------------------------------------------
⏷ Show the Full List of 711 DOT(s)
Indication(s) of Paclitaxel
Disease Entry ICD 11 Status REF
Breast carcinoma N.A. Approved [5]
Cutaneous melanoma 2C30 Approved [5]
Cutaneous squamous cell carcinoma 2C30 Approved [5]
Epithelial ovarian cancer 2B5D Approved [5]
Extragonadal germ cell tumor N.A. Approved [5]
Fallopian tube neoplasm N.A. Approved [5]
Gastroesophageal junction adenocarcinoma 2B71 Approved [5]
Inflammatory breast cancer 2C62 Approved [5]
Kaposi sarcoma 2B57 Approved [5]
Lung adenocarcinoma N.A. Approved [5]
Lung cancer 2C25.0 Approved [5]
Non-small-cell lung cancer 2C25.Y Approved [5]
Ocular hypertension 9C61.01 Approved [5]
Ovarian neoplasm N.A. Approved [5]
Ovarian serous cystadenocarcinoma N.A. Approved [5]
Pain MG30-MG3Z Approved [5]
Pancreatic ductal carcinoma 2C10.0 Approved [5]
Primary peritoneal carcinoma N.A. Approved [5]
Testicular germ cell tumor N.A. Approved [5]
Urethral cancer 2C93 Approved [5]
Lung large cell carcinoma N.A. Investigative [5]
Paclitaxel Interacts with 11 DTP Molecule(s)
DTP Name DTP ID UniProt ID Mode of Action REF
Multidrug resistance-associated protein 1 (ABCC1) DTSYQGK MRP1_HUMAN Substrate [49]
Multidrug resistance-associated protein 2 (ABCC2) DTFI42L MRP2_HUMAN Substrate [50]
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [51]
Breast cancer resistance protein (ABCG2) DTI7UX6 ABCG2_HUMAN Substrate [52]
Organic anion transporter 2 (SLC22A7) DT0OC1Q S22A7_HUMAN Substrate [53]
Organic anion transporting polypeptide 1B1 (SLCO1B1) DT3D8F0 SO1B1_HUMAN Substrate [54]
Multidrug resistance-associated protein 3 (ABCC3) DTQ3ZHF MRP3_HUMAN Substrate [55]
Multidrug resistance protein 3 (ABCB4) DTZRMK5 MDR3_HUMAN Substrate [56]
Organic anion transporting polypeptide 1B3 (SLCO1B3) DT9C1TS SO1B3_HUMAN Substrate [57]
TAP-like protein (ABCB9) DT68UV2 ABCB9_HUMAN Substrate [58]
Multidrug resistance-associated protein 7 (ABCC10) DTPS120 MRP7_HUMAN Substrate [59]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 DTP(s)
Paclitaxel Interacts with 478 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Broad substrate specificity ATP-binding cassette transporter ABCG2 (ABCG2) OTW8V2V1 ABCG2_HUMAN Decreases Expression [60]
ATP-binding cassette sub-family C member 10 (ABCC10) OT2JRWWJ MRP7_HUMAN Increases Expression [61]
ATP-binding cassette sub-family C member 3 (ABCC3) OTC3IJV4 MRP3_HUMAN Increases Expression [61]
ATP-binding cassette sub-family C member 2 (ABCC2) OTJSIGV5 MRP2_HUMAN Decreases Response To Substance [62]
Multidrug resistance-associated protein 1 (ABCC1) OTGUN89S MRP1_HUMAN Decreases Response To Substance [63]
ATP-dependent translocase ABCB1 (ABCB1) OTEJROBO MDR1_HUMAN Decreases Response To Substance [64]
Phosphatidylcholine translocator ABCB4 (ABCB4) OTE6PY83 MDR3_HUMAN Decreases Response To Substance [65]
Solute carrier family 22 member 7 (SLC22A7) OTKTNH1W S22A7_HUMAN Increases Transport [53]
Cyclin-dependent kinase 20 (CDK20) OTOLNN68 CDK20_HUMAN Decreases Expression [66]
Alkaline phosphatase, tissue-nonspecific isozyme (ALPL) OTG7J4BP PPBT_HUMAN Increases ADR [34]
Lipoprotein lipase (LPL) OTTW0267 LIPL_HUMAN Increases ADR [34]
Mitogen-activated protein kinase 1 (MAPK1) OTH85PI5 MK01_HUMAN Decreases Activity [67]
Cellular tumor antigen p53 (TP53) OTIE1VH3 P53_HUMAN Increases Expression [68]
TNF receptor-associated factor 1 (TRAF1) OTTLM5RU TRAF1_HUMAN Decreases Expression [66]
Baculoviral IAP repeat-containing protein 3 (BIRC3) OT3E95KB BIRC3_HUMAN Decreases Expression [69]
Baculoviral IAP repeat-containing protein 2 (BIRC2) OTFXFREP BIRC2_HUMAN Decreases Expression [69]
Bcl2-associated agonist of cell death (BAD) OT63ERYM BAD_HUMAN Increases Expression [41]
Poly polymerase 1 (PARP1) OTIESHK4 PARP1_ARATH Increases ADR [34]
Nuclear receptor subfamily 1 group I member 2 (NR1I2) OTC5U0N5 NR1I2_HUMAN Increases Activity [70]
Aromatase (CYP19A1) OTZ6XF74 CP19A_HUMAN Increases Activity [71]
Cytochrome P450 3A4 (CYP3A4) OTQGYY83 CP3A4_HUMAN Increases Expression [72]
Dihydropyrimidine dehydrogenase (DPYD) OTWRF2NR DPYD_HUMAN Decreases Expression [37]
Arylamine N-acetyltransferase 1 (NAT1) OTCCNQ3H ARY1_HUMAN Decreases Activity [73]
NAD-dependent protein deacetylase sirtuin-1 (SIRT1) OTAYZMOY SIR1_HUMAN Decreases Expression [74]
Nitric oxide synthase 3 (NOS3) OTLDT7NR NOS3_HUMAN Decreases Expression [67]
Microtubule-associated proteins 1A/1B light chain 3B (MAP1LC3B) OTUYHB84 MLP3B_HUMAN Increases Expression [67]
Cytochrome P450 1A2 (CYP1A2) OTLLBX48 CP1A2_HUMAN Decreases Activity [75]
Cytochrome P450 2D6 (CYP2D6) OTZJC802 CP2D6_HUMAN Decreases Activity [75]
Cytochrome P450 2C9 (CYP2C9) OTGLBN29 CP2C9_HUMAN Decreases Activity [75]
Bile salt export pump (ABCB11) OTRU7THO ABCBB_HUMAN Decreases Activity [76]
Tumor necrosis factor receptor superfamily member 10A (TNFRSF10A) OTBPCU2O TR10A_HUMAN Increases Expression [77]
DNA fragmentation factor subunit alpha (DFFA) OTFPFMT8 DFFA_HUMAN Decreases Expression [39]
Sulfhydryl oxidase 1 (QSOX1) OT4ZPK4P QSOX1_HUMAN Decreases Expression [38]
Serine/threonine-protein kinase PLK4 (PLK4) OTV8KZDZ PLK4_HUMAN Decreases Expression [38]
TNF receptor-associated factor 5 (TRAF5) OTSBTLO0 TRAF5_HUMAN Decreases Expression [38]
Myc box-dependent-interacting protein 1 (BIN1) OTK8O0X8 BIN1_HUMAN Increases Expression [78]
Nucleoside diphosphate kinase, mitochondrial (NME4) OT2JTT42 NDKM_HUMAN Decreases Expression [39]
Potassium channel subfamily K member 3 (KCNK3) OTWMAV6G KCNK3_HUMAN Increases Expression [39]
Apoptotic protease-activating factor 1 (APAF1) OTJWIVY0 APAF_HUMAN Increases Expression [69]
Acyl-coenzyme A thioesterase 8 (ACOT8) OTHY684G ACOT8_HUMAN Decreases Expression [79]
Telomerase reverse transcriptase (TERT) OT085VVA TERT_HUMAN Decreases Expression [80]
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) OTA1CPBV TR10B_HUMAN Increases Expression [77]
Neuropilin-1 (NRP1) OTCGULYV NRP1_HUMAN Increases Expression [78]
Aurora kinase A (AURKA) OTMX0HYT AURKA_HUMAN Increases Expression [81]
Mitogen-activated protein kinase 13 (MAPK13) OT0W9GE7 MK13_HUMAN Increases Expression [39]
Baculoviral IAP repeat-containing protein 5 (BIRC5) OTILXZYL BIRC5_HUMAN Decreases Expression [82]
High affinity copper uptake protein 1 (SLC31A1) OTXLRTUB COPT1_HUMAN Increases Expression [61]
ATP-binding cassette sub-family C member 5 (ABCC5) OT34G4US MRP5_HUMAN Increases Expression [61]
N-glycosylase/DNA lyase (OGG1) OTJ97TF3 OGG1_HUMAN Increases Expression [39]
Retinoschisin (RS1) OTEW1ZM5 XLRS1_HUMAN Decreases Secretion [83]
Kunitz-type protease inhibitor 2 (SPINT2) OTQV7BKQ SPIT2_HUMAN Decreases Expression [78]
Adenylate cyclase type 6 (ADCY6) OTFOY4WW ADCY6_HUMAN Decreases Expression [38]
Protein regulator of cytokinesis 1 (PRC1) OTHD0XS0 PRC1_HUMAN Increases Expression [81]
Mitotic checkpoint protein BUB3 (BUB3) OTU91HAU BUB3_HUMAN Increases Expression [39]
Phospholipid phosphatase 2 (PLPP2) OT0BQAXX PLPP2_HUMAN Decreases Expression [78]
Myelin protein zero-like protein 2 (MPZL2) OTKFNDUI MPZL2_HUMAN Decreases Expression [78]
Dual specificity protein phosphatase CDC14B (CDC14B) OTAESVOZ CC14B_HUMAN Decreases Expression [66]
Hyaluronan mediated motility receptor (HMMR) OT4M0JTZ HMMR_HUMAN Decreases Expression [39]
Serine/threonine-protein kinase/endoribonuclease IRE1 (ERN1) OTY9R6FZ ERN1_HUMAN Increases Expression [84]
Death effector domain-containing protein (DEDD) OTIL349E DEDD_HUMAN Decreases Expression [38]
Serine hydrolase RBBP9 (RBBP9) OT0Z04L6 RBBP9_HUMAN Decreases Expression [38]
Tumor necrosis factor ligand superfamily member 13 (TNFSF13) OT90OWIO TNF13_HUMAN Increases Expression [66]
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial (CLPX) OTIT4JL0 CLPX_HUMAN Increases Expression [39]
Apoptosis-inducing factor 1, mitochondrial (AIFM1) OTKPWB7Q AIFM1_HUMAN Increases Expression [66]
Securin (PTTG1) OTIMYS4W PTTG1_HUMAN Affects Expression [85]
G1/S-specific cyclin-E2 (CCNE2) OTBBUKQQ CCNE2_HUMAN Decreases Expression [38]
Aldehyde dehydrogenase 1A1 (ALDH1A1) OTCUWZKB AL1A1_HUMAN Decreases Expression [86]
Epidermal growth factor receptor (EGFR) OTAPLO1S EGFR_HUMAN Decreases Expression [66]
Myc proto-oncogene protein (MYC) OTPV5LUK MYC_HUMAN Decreases Expression [39]
Pro-epidermal growth factor (EGF) OTANRJ0L EGF_HUMAN Decreases Expression [66]
Interleukin-1 beta (IL1B) OT0DWXXB IL1B_HUMAN Increases Expression [87]
Collagen alpha-1(I) chain (COL1A1) OTI31178 CO1A1_HUMAN Increases Expression [78]
Collagen alpha-1(IV) chain (COL4A1) OTL6D1YE CO4A1_HUMAN Increases Expression [78]
Estrogen receptor (ESR1) OTKLU61J ESR1_HUMAN Increases Expression [88]
RAF proto-oncogene serine/threonine-protein kinase (RAF1) OT51LSFO RAF1_HUMAN Increases Phosphorylation [89]
Superoxide dismutase , mitochondrial (SOD2) OTIWXGZ9 SODM_HUMAN Increases Expression [90]
Thy-1 membrane glycoprotein (THY1) OTVONVTB THY1_HUMAN Increases Expression [78]
Apolipoprotein D (APOD) OTT77XW8 APOD_HUMAN Increases Expression [78]
Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCA) OTWJTCRK PCCA_HUMAN Decreases Expression [39]
Eukaryotic translation initiation factor 2 subunit 1 (EIF2S1) OTM0GDTP IF2A_HUMAN Increases Phosphorylation [84]
Interleukin-6 (IL6) OTUOSCCU IL6_HUMAN Increases Expression [91]
Intercellular adhesion molecule 1 (ICAM1) OTTOIX77 ICAM1_HUMAN Decreases Expression [92]
Transcription factor Jun (JUN) OTCYBO6X JUN_HUMAN Increases Phosphorylation [93]
Transcription factor AP-2-alpha (TFAP2A) OTMYT3NK AP2A_HUMAN Increases Expression [94]
Keratin, type I cytoskeletal 18 (KRT18) OTVLQFIP K1C18_HUMAN Increases Expression [95]
Gelsolin (GSN) OT4KS2UU GELS_HUMAN Decreases Expression [38]
Retinoblastoma-associated protein (RB1) OTQJUJMZ RB_HUMAN Increases Phosphorylation [96]
Cyclin-dependent kinase 1 (CDK1) OTW1SC2N CDK1_HUMAN Decreases Expression [66]
Fatty acid-binding protein, liver (FABP1) OTR34ETM FABPL_HUMAN Decreases Expression [79]
Prosaposin (PSAP) OTUOEKY7 SAP_HUMAN Decreases Expression [38]
Collagen alpha-2(IV) chain (COL4A2) OTJK1LKN CO4A2_HUMAN Increases Expression [78]
SPARC (SPARC) OTPN90H0 SPRC_HUMAN Increases Expression [78]
Poly polymerase 1 (PARP1) OT310QSG PARP1_HUMAN Increases Cleavage [97]
Interleukin-8 (CXCL8) OTS7T5VH IL8_HUMAN Increases Expression [91]
Androgen receptor (AR) OTUBKAZZ ANDR_HUMAN Decreases Localization [98]
Microtubule-associated protein tau (MAPT) OTMTP2Z7 TAU_HUMAN Decreases Expression [99]
Cyclin-dependent kinase 4 (CDK4) OT7EP05T CDK4_HUMAN Decreases Expression [100]
Proliferating cell nuclear antigen (PCNA) OTHZ1RIA PCNA_HUMAN Decreases Expression [100]
Collagen alpha-1(VI) chain (COL6A1) OTYKSCOB CO6A1_HUMAN Increases Expression [78]
Collagen alpha-2(VI) chain (COL6A2) OTQC6PPO CO6A2_HUMAN Increases Expression [78]
ADP/ATP translocase 1 (SLC25A4) OTKYLK2J ADT1_HUMAN Decreases Expression [38]
Bone morphogenetic protein 4 (BMP4) OTPZMDFH BMP4_HUMAN Decreases Expression [42]
Elongation factor 2 (EEF2) OTZ7SZ39 EF2_HUMAN Decreases Expression [38]
Glial fibrillary acidic protein (GFAP) OTQ01ZAS GFAP_HUMAN Increases Expression [101]
Interleukin-1 receptor type 1 (IL1R1) OTTU8959 IL1R1_HUMAN Decreases Expression [39]
Amphiregulin (AREG) OTJFOR67 AREG_HUMAN Increases Expression [102]
Histone H2AX (H2AX) OT18UX57 H2AX_HUMAN Increases Expression [103]
Epithelial cell adhesion molecule (EPCAM) OTHBZK5X EPCAM_HUMAN Decreases Expression [78]
Integrin beta-6 (ITGB6) OTI3DJ7U ITB6_HUMAN Decreases Expression [78]
Cyclic AMP-dependent transcription factor ATF-4 (ATF4) OTRFV19J ATF4_HUMAN Increases Expression [84]
DNA ligase 1 (LIG1) OTEEQS43 DNLI1_HUMAN Decreases Expression [38]
Sodium/hydrogen exchanger 1 (SLC9A1) OT6HNHFV SL9A1_HUMAN Decreases Activity [104]
Integrin alpha-L (ITGAL) OTCUQAIS ITAL_HUMAN Decreases Expression [92]
Ephrin-A1 (EFNA1) OTU2NUA2 EFNA1_HUMAN Decreases Expression [78]
Tumor necrosis factor alpha-induced protein 3 (TNFAIP3) OTVLI4DD TNAP3_HUMAN Increases Expression [66]
Interleukin-10 (IL10) OTIRFRXC IL10_HUMAN Increases Expression [91]
Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1) OTBZKX4P ROA2_HUMAN Decreases Expression [38]
Insulin-like growth factor-binding protein 4 (IGFBP4) OT2HZRBD IBP4_HUMAN Increases Expression [78]
Carnitine O-palmitoyltransferase 2, mitochondrial (CPT2) OTIN6G20 CPT2_HUMAN Decreases Expression [79]
Follicle-stimulating hormone receptor (FSHR) OT9MVMLI FSHR_HUMAN Decreases Expression [42]
G1/S-specific cyclin-D1 (CCND1) OT8HPTKJ CCND1_HUMAN Decreases Expression [100]
Cyclin-dependent kinase 2 (CDK2) OTB5DYYZ CDK2_HUMAN Increases Activity [105]
Signal transducer CD24 (CD24) OT7CODJ4 CD24_HUMAN Decreases Expression [78]
Tumor necrosis factor receptor superfamily member 6 (FAS) OTP9XG86 TNR6_HUMAN Decreases Expression [106]
Protein S100-P (S100P) OTJCXNJG S100P_HUMAN Decreases Expression [78]
Protein S100-A4 (S100A4) OTLRGFSQ S10A4_HUMAN Increases Expression [78]
Mitogen-activated protein kinase 3 (MAPK3) OTCYKGKO MK03_HUMAN Decreases Phosphorylation [42]
Long-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADL) OTP7Y0UF ACADL_HUMAN Decreases Expression [39]
Caspase-1 (CASP1) OTZ3YQFU CASP1_HUMAN Increases Expression [87]
M-phase inducer phosphatase 3 (CDC25C) OTPQI71S MPIP3_HUMAN Decreases Expression [66]
Adenylosuccinate synthetase isozyme 2 (ADSS2) OTW26XXB PURA2_HUMAN Decreases Expression [39]
RAC-beta serine/threonine-protein kinase (AKT2) OTBB632K AKT2_HUMAN Increases Phosphorylation [107]
Heterogeneous nuclear ribonucleoprotein H (HNRNPH1) OTFRWOLM HNRH1_HUMAN Decreases Expression [38]
Stress-induced-phosphoprotein 1 (STIP1) OT7TXLOX STIP1_HUMAN Increases Expression [39]
Syndecan-2 (SDC2) OTEEHY1D SDC2_HUMAN Increases Expression [78]
Catenin beta-1 (CTNNB1) OTZ932A3 CTNB1_HUMAN Decreases Phosphorylation [42]
Tyrosine-protein phosphatase non-receptor type 7 (PTPN7) OTXYSIIV PTN7_HUMAN Increases Expression [39]
Prostaglandin G/H synthase 2 (PTGS2) OT75U9M4 PGH2_HUMAN Decreases Expression [39]
Fibrillin-1 (FBN1) OTYCJT63 FBN1_HUMAN Increases Expression [78]
DNA damage-inducible transcript 3 protein (DDIT3) OTI8YKKE DDIT3_HUMAN Increases Expression [84]
Pigment epithelium-derived factor (SERPINF1) OTWZH98J PEDF_HUMAN Increases Expression [78]
Breast cancer type 1 susceptibility protein (BRCA1) OT5BN6VH BRCA1_HUMAN Decreases Expression [108]
Cyclin-dependent kinase inhibitor 1 (CDKN1A) OTQWHCZE CDN1A_HUMAN Decreases Expression [109]
Collagen alpha-1(XVIII) chain (COL18A1) OTJFUH6O COIA1_HUMAN Increases Expression [78]
Signal transducer and activator of transcription 3 (STAT3) OTAAGKYZ STAT3_HUMAN Decreases Activity [110]
Replication factor C subunit 5 (RFC5) OTAD79RT RFC5_HUMAN Decreases Expression [39]
Serine/threonine-protein kinase mTOR (MTOR) OTHH8KU7 MTOR_HUMAN Decreases Phosphorylation [100]
Caspase-3 (CASP3) OTIJRBE7 CASP3_HUMAN Increases Expression [111]
Mitogen-activated protein kinase 8 (MAPK8) OTEREYS5 MK08_HUMAN Increases Activity [112]
Mitogen-activated protein kinase 9 (MAPK9) OTCEVJ9E MK09_HUMAN Increases Expression [113]
Tumor necrosis factor ligand superfamily member 6 (FASLG) OTZARCHH TNFL6_HUMAN Increases Expression [114]
Isocitrate dehydrogenase , mitochondrial (IDH2) OTTQA4PB IDHP_HUMAN Decreases Expression [38]
4-trimethylaminobutyraldehyde dehydrogenase (ALDH9A1) OTNWHUJ1 AL9A1_HUMAN Increases Expression [39]
Fatty acid synthase (FASN) OTFII9KG FAS_HUMAN Decreases Expression [79]
Centromere protein F (CENPF) OT7AG0SW CENPF_HUMAN Increases Expression [115]
Caspase-4 (CASP4) OTVQTV1L CASP4_HUMAN Increases Expression [66]
NADH dehydrogenase flavoprotein 1, mitochondrial (NDUFV1) OTEVK4WW NDUV1_HUMAN Decreases Expression [38]
Glycogen synthase kinase-3 beta (GSK3B) OTL3L14B GSK3B_HUMAN Increases Phosphorylation [116]
Carnitine O-palmitoyltransferase 1, liver isoform (CPT1A) OTI862QH CPT1A_HUMAN Decreases Expression [79]
Tumor necrosis factor ligand superfamily member 10 (TNFSF10) OT4PXBTA TNF10_HUMAN Increases Expression [39]
Cyclin-dependent kinase 7 (CDK7) OTAO19PQ CDK7_HUMAN Increases Activity [117]
Palmitoyl-protein thioesterase 1 (PPT1) OTM3S4DE PPT1_HUMAN Decreases Expression [79]
Dual specificity protein phosphatase 3 (DUSP3) OTPJX9B4 DUS3_HUMAN Decreases Expression [38]
Matrix metalloproteinase-16 (MMP16) OTSFQ2BJ MMP16_HUMAN Decreases Expression [66]
Caspase-5 (CASP5) OT0F2THD CASP5_HUMAN Increases Expression [66]
Cyclin-H (CCNH) OTKDU3SR CCNH_HUMAN Increases Expression [39]
Activated RNA polymerase II transcriptional coactivator p15 (SUB1) OTK71JYU TCP4_HUMAN Decreases Expression [39]
Epithelial membrane protein 3 (EMP3) OTODMJ1D EMP3_HUMAN Increases Expression [78]
Caspase-7 (CASP7) OTAPJ040 CASP7_HUMAN Increases Expression [66]
Caspase-9 (CASP9) OTD4RFFG CASP9_HUMAN Increases Expression [66]
Cadherin-11 (CDH11) OTIZKPTF CAD11_HUMAN Increases Expression [78]
Tumor protein D52 (TPD52) OTPKSK43 TPD52_HUMAN Decreases Expression [78]
BH3-interacting domain death agonist (BID) OTOSHSHU BID_HUMAN Increases Cleavage [101]
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN) OTOWDUNT PTEN_HUMAN Increases Activity [118]
Eukaryotic initiation factor 4A-I (EIF4A1) OTMTBX6N IF4A1_HUMAN Decreases Expression [39]
Actin, aortic smooth muscle (ACTA2) OTEDLG8E ACTA_HUMAN Increases Expression [119]
Ras-related C3 botulinum toxin substrate 1 (RAC1) OTKRO61U RAC1_HUMAN Decreases Expression [38]
SH3 domain-binding protein 2 (SH3BP2) OT90JNBS 3BP2_HUMAN Decreases Expression [39]
General transcription factor II-I (GTF2I) OTUYL1TQ GTF2I_HUMAN Decreases Expression [38]
Cytochrome c (CYCS) OTBFALJD CYC_HUMAN Increases Expression [39]
Cyclin-dependent kinase 6 (CDK6) OTR95N0X CDK6_HUMAN Decreases Expression [100]
Antigen peptide transporter 1 (TAP1) OTJL27PW TAP1_HUMAN Increases Expression [61]
Transcription factor p65 (RELA) OTUJP9CN TF65_HUMAN Decreases Expression [80]
Copper-transporting ATPase 1 (ATP7A) OTMR3GXP ATP7A_HUMAN Increases Expression [61]
Protein kinase C delta type (PRKCD) OTSEH90E KPCD_HUMAN Affects Localization [90]
Apoptosis regulator BAX (BAX) OTAW0V4V BAX_HUMAN Increases Expression [41]
Bcl-2-like protein 1 (BCL2L1) OTRC5K9O B2CL1_HUMAN Decreases Expression [66]
Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1) OT2YYI1A MCL1_HUMAN Decreases Expression [69]
Heat shock protein beta-3 (HSPB3) OTE67YM5 HSPB3_HUMAN Increases Expression [39]
Lymphocyte cytosolic protein 2 (LCP2) OT57KE22 LCP2_HUMAN Increases Expression [39]
FAS-associated death domain protein (FADD) OTV7GFHH FADD_HUMAN Increases Expression [66]
Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) OTS3FVTY M3K1_HUMAN Increases Cleavage [112]
MAGUK p55 subfamily member 3 (MPP3) OTNOL0HA MPP3_HUMAN Increases Expression [39]
Rho-associated protein kinase 1 (ROCK1) OTSXYVW1 ROCK1_HUMAN Increases Expression [38]
Short transient receptor potential channel 3 (TRPC3) OTNR61OD TRPC3_HUMAN Increases Expression [39]
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (ENPP2) OTTUU92F ENPP2_HUMAN Increases Expression [78]
Protein-tyrosine kinase 6 (PTK6) OT7NWIQ0 PTK6_HUMAN Increases Expression [38]
Interleukin-18 (IL18) OTBB2A8O IL18_HUMAN Increases Expression [87]
Protein BTG3 (BTG3) OT9ANHVT BTG3_HUMAN Increases Expression [39]
Src substrate cortactin (CTTN) OTJRG4ES SRC8_HUMAN Decreases Expression [39]
Caprin-1 (CAPRIN1) OTEJAMS3 CAPR1_HUMAN Decreases Expression [66]
Caspase-8 (CASP8) OTA8TVI8 CASP8_HUMAN Increases Expression [66]
Periostin (POSTN) OTWP62UA POSTN_HUMAN Increases Expression [78]
Procollagen C-endopeptidase enhancer 1 (PCOLCE) OTJXOAN4 PCOC1_HUMAN Increases Expression [78]
Transcription factor E2F5 (E2F5) OT1XWING E2F5_HUMAN Increases Expression [38]
Microtubule-associated protein RP/EB family member 1 (MAPRE1) OTCVQD60 MARE1_HUMAN Decreases Localization [120]
Bcl-2 homologous antagonist/killer (BAK1) OTDP6ILW BAK_HUMAN Increases Expression [41]
Transcriptional regulator QRICH1 (QRICH1) OTPVAX04 QRIC1_HUMAN Increases Phosphorylation [121]
Parafibromin (CDC73) OT6JASZ1 CDC73_HUMAN Decreases Expression [66]
Inactive caspase-12 (CASP12) OTY2W6FG CASPC_HUMAN Decreases Expression [80]
Heme A synthase COX15 (COX15) OTUIYHIW COX15_HUMAN Decreases Expression [38]
Ribonucleoside-diphosphate reductase subunit M2 B (RRM2B) OTE8GBUR RIR2B_HUMAN Increases Expression [122]
Cell division cycle and apoptosis regulator protein 1 (CCAR1) OTUXLQZZ CCAR1_HUMAN Increases Expression [66]
NAD-dependent protein deacetylase sirtuin-2 (SIRT2) OT5Q6SVK SIR2_HUMAN Decreases Expression [84]
Abnormal spindle-like microcephaly-associated protein (ASPM) OTKXQMNA ASPM_HUMAN Increases Expression [81]
Phospholipid-transporting ATPase ABCA7 (ABCA7) OT51S50X ABCA7_HUMAN Increases Expression [61]
Centromere protein S (CENPS) OTZ4J391 CENPS_HUMAN Increases Expression [66]
NAD-dependent protein deacylase sirtuin-6 (SIRT6) OTF755ZO SIR6_HUMAN Decreases Expression [84]
Cholesterol transporter ABCA5 (ABCA5) OT4B9D92 ABCA5_HUMAN Increases Expression [61]
MAP kinase-activating death domain protein (MADD) OTUFYVGG MADD_HUMAN Decreases Expression [38]
Mucin-16 (MUC16) OTHPPE67 MUC16_HUMAN Decreases Expression [123]
Rap guanine nucleotide exchange factor 5 (RAPGEF5) OT53VS75 RPGF5_HUMAN Increases Expression [39]
Estrogen receptor beta (ESR2) OTXNR2WQ ESR2_HUMAN Decreases Expression [42]
Transcription factor AP-2 gamma (TFAP2C) OTUDIW05 AP2C_HUMAN Decreases Expression [78]
Caspase-10 (CASP10) OTE6J88E CASPA_HUMAN Increases Expression [66]
Engulfment and cell motility protein 3 (ELMO3) OTQHO9VM ELMO3_HUMAN Increases Expression [39]
p53 apoptosis effector related to PMP-22 (PERP) OTP0YL53 PERP_HUMAN Increases Expression [66]
Bcl-2-binding component 3, isoforms 3/4 (BBC3) OTUAXDAY BBC3B_HUMAN Increases Expression [124]
Cell division cycle 5-like protein (CDC5L) OTTPFUU5 CDC5L_HUMAN Decreases Expression [66]
M-phase phosphoprotein 6 (MPHOSPH6) OT6E2S48 MPH6_HUMAN Decreases Expression [39]
Heterogeneous nuclear ribonucleoprotein A/B (HNRNPAB) OTUKPFOK ROAA_HUMAN Decreases Expression [38]
Transmembrane protein 243 (TMEM243) OT8NQ79G TM243_HUMAN Increases Expression [125]
Cell division cycle-associated protein 7 (CDCA7) OT12HDZY CDCA7_HUMAN Decreases Expression [66]
Transmembrane gamma-carboxyglutamic acid protein 4 (PRRG4) OT2SZQI7 TMG4_HUMAN Decreases Expression [78]
TRIO and F-actin-binding protein (TRIOBP) OTGB5WHC TARA_HUMAN Increases Expression [39]
ATP-binding cassette sub-family B member 6 (ABCB6) OTPGZFES ABCB6_HUMAN Decreases Expression [61]
Bridging integrator 3 (BIN3) OTMIWWDW BIN3_HUMAN Decreases Expression [39]
Diablo IAP-binding mitochondrial protein (DIABLO) OTHJ9MCZ DBLOH_HUMAN Increases Expression [80]
NAD-dependent protein deacetylase sirtuin-7 (SIRT7) OT5M4OT4 SIR7_HUMAN Decreases Expression [84]
Olfactomedin-like protein 3 (OLFML3) OTDN45FN OLFL3_HUMAN Increases Expression [78]
G2 and S phase-expressed protein 1 (GTSE1) OTPP742Z GTSE1_HUMAN Increases Expression [39]
ETS homologous factor (EHF) OTY6TPWD EHF_HUMAN Decreases Expression [78]
Programmed cell death 1 ligand 1 (CD274) OTJ0VFDL PD1L1_HUMAN Increases Expression [126]
DNA polymerase kappa (POLK) OTKZ38JH POLK_HUMAN Decreases Expression [38]
Protein Hook homolog 1 (HOOK1) OTTTKV7V HOOK1_HUMAN Decreases Expression [78]
PR domain zinc finger protein 4 (PRDM4) OTD9PAZJ PRDM4_HUMAN Decreases Expression [39]
F-box only protein 5 (FBXO5) OTTR957W FBX5_HUMAN Affects Expression [85]
Neurabin-1 (PPP1R9A) OTJL2TOC NEB1_HUMAN Decreases Expression [38]
Matrix metalloproteinase-17 (MMP17) OT5TMIQ6 MMP17_HUMAN Decreases Expression [66]
Microtubule-associated protein RP/EB family member 3 (MAPRE3) OTSCLETV MARE3_HUMAN Affects Localization [120]
Cyclin-D-binding Myb-like transcription factor 1 (DMTF1) OTDKO9OO DMTF1_HUMAN Decreases Expression [38]
RuvB-like 2 (RUVBL2) OTGWJ4T4 RUVB2_HUMAN Decreases Expression [39]
C-type lectin domain family 11 member A (CLEC11A) OT9KBH7C CLC11_HUMAN Increases Expression [78]
Tumor necrosis factor ligand superfamily member 13B (TNFSF13B) OTND26XR TN13B_HUMAN Increases Expression [66]
Cyclic AMP-dependent transcription factor ATF-5 (ATF5) OT03QCLM ATF5_HUMAN Decreases Expression [38]
Protein-arginine deiminase type-2 (PADI2) OTT40K94 PADI2_HUMAN Decreases Expression [39]
Mitochondrial import inner membrane translocase subunit Tim22 (TIMM22) OTJMHX1V TIM22_HUMAN Increases Expression [39]
Small ribosomal subunit protein mS40 (MRPS18B) OT1K9PFX RT18B_HUMAN Decreases Expression [39]
Transforming acidic coiled-coil-containing protein 3 (TACC3) OTRNEZTA TACC3_HUMAN Decreases Expression [39]
Sorting nexin-10 (SNX10) OT05B7BT SNX10_HUMAN Affects Response To Substance [44]
Superoxide dismutase (SOD2) OT08HOR5 Q4ZJI1_HUMAN Increases ADR [34]
Eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3) OT0DZGY4 E2AK3_HUMAN Affects Response To Substance [44]
Nuclear factor erythroid 2-related factor 2 (NFE2L2) OT0HENJ5 NF2L2_HUMAN Decreases Response To Substance [127]
Phospholipid phosphatase 1 (PLPP1) OT0IIMI5 PLPP1_HUMAN Decreases Response To Substance [128]
Interleukin-17 receptor B (IL17RB) OT0KDNSF I17RB_HUMAN Decreases Response To Substance [128]
Oxysterol-binding protein-related protein 10 (OSBPL10) OT0TFMBE OSB10_HUMAN Affects Response To Substance [44]
NADH dehydrogenase 1 alpha subcomplex subunit 13 (NDUFA13) OT0UOKIT NDUAD_HUMAN Affects Response To Substance [44]
Tripartite motif-containing protein 2 (TRIM2) OT0V1YVC TRIM2_HUMAN Affects Response To Substance [44]
G2/mitotic-specific cyclin-B1 (CCNB1) OT19S7E5 CCNB1_HUMAN Increases Response To Substance [129]
Condensin complex subunit 3 (NCAPG) OT1AI9EO CND3_HUMAN Affects Response To Substance [44]
Integrin beta-5 (ITGB5) OT21MF51 ITB5_HUMAN Decreases Response To Substance [64]
NADH dehydrogenase 1 beta subcomplex subunit 7 (NDUFB7) OT2CHQQ1 NDUB7_HUMAN Affects Response To Substance [44]
Aldehyde oxidase (AOX1) OT2FZP6H AOXA_HUMAN Affects Response To Substance [44]
U11/U12 small nuclear ribonucleoprotein 25 kDa protein (SNRNP25) OT2MR6O2 SNR25_HUMAN Affects Response To Substance [44]
Epidermal growth factor-like protein 6 (EGFL6) OT331X59 EGFL6_HUMAN Decreases Response To Substance [47]
Biglycan (BGN) OT3AV6IF PGS1_HUMAN Affects Response To Substance [44]
Cytidine deaminase (CDA) OT3HXP6N CDD_HUMAN Affects Response To Substance [130]
Collagen alpha-1(VII) chain (COL7A1) OT3MIRZJ CO7A1_HUMAN Increases Response To Substance [128]
Solute carrier family 12 member 2 (SLC12A2) OT3ZJ3LH S12A2_HUMAN Decreases Response To Substance [128]
NADH dehydrogenase 1 beta subcomplex subunit 2, mitochondrial (NDUFB2) OT4717TF NDUB2_HUMAN Affects Response To Substance [44]
High mobility group protein B1 (HMGB1) OT4B7CPF HMGB1_HUMAN Affects Response To Substance [44]
Deoxycytidylate deaminase (DCTD) OT4FLFT4 DCTD_HUMAN Affects Response To Substance [44]
Sorcin (SRI) OT4R3EAC SORCN_HUMAN Decreases Response To Substance [131]
Beclin-1 (BECN1) OT4X293M BECN1_HUMAN Affects Response To Substance [87]
Ubiquitin-like protein ISG15 (ISG15) OT53QQ7N ISG15_HUMAN Affects Response To Substance [44]
MARVEL domain-containing protein 1 (MARVELD1) OT5CPOJE MALD1_HUMAN Increases Response To Substance [132]
Small ribosomal subunit protein uS15m (MRPS15) OT5HRAPP RT15_HUMAN Affects Response To Substance [44]
RAC-gamma serine/threonine-protein kinase (AKT3) OT5M2LFI AKT3_HUMAN Affects Response To Substance [107]
Signal recognition particle receptor subunit alpha (SRPRA) OT5NMYTY SRPRA_HUMAN Affects Response To Substance [44]
Annexin A1 (ANXA1) OT5OFDJC ANXA1_HUMAN Increases Response To Substance [128]
Beta-sarcoglycan (SGCB) OT5R5LAT SGCB_HUMAN Affects Response To Substance [44]
Collagen alpha-2(V) chain (COL5A2) OT5VOSQE CO5A2_HUMAN Decreases Response To Substance [47]
Transmembrane protein 135 (TMEM135) OT63ZT3X TM135_HUMAN Affects Response To Substance [44]
Farnesyl pyrophosphate synthase (FDPS) OT6CKWV5 FPPS_HUMAN Increases Response To Substance [64]
Ferritin heavy chain (FTH1) OT6IFS0O FRIH_HUMAN Decreases Response To Substance [64]
DNA topoisomerase 2-alpha (TOP2A) OT6LPS08 TOP2A_HUMAN Increases Response To Substance [64]
Claudin-3 (CLDN3) OT71MN9S CLD3_HUMAN Decreases Response To Substance [128]
Plasminogen activator inhibitor 2 (SERPINB2) OT72QLZB PAI2_HUMAN Affects Response To Substance [44]
DNA-binding protein RFX5 (RFX5) OT73KJ5P RFX5_HUMAN Decreases Response To Substance [64]
CD40 ligand (CD40LG) OT75Z6A6 CD40L_HUMAN Decreases Response To Substance [133]
Large ribosomal subunit protein P1 (RPLP1) OT7B0SIB RLA1_HUMAN Decreases Response To Substance [64]
Fibroblast growth factor 2 (FGF2) OT7YUJ9F FGF2_HUMAN Decreases Response To Substance [134]
Nucleolar and spindle-associated protein 1 (NUSAP1) OT85HIJ5 NUSAP_HUMAN Affects Response To Substance [44]
Peroxisomal multifunctional enzyme type 2 (HSD17B4) OT8733D7 DHB4_HUMAN Affects Response To Substance [44]
RAC-alpha serine/threonine-protein kinase (AKT1) OT8H2YY7 AKT1_HUMAN Decreases Response To Substance [135]
Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (BUB1B) OT8KME51 BUB1B_HUMAN Affects Response To Substance [136]
Thrombomodulin (THBD) OT8VHLKY TRBM_HUMAN Decreases Response To Substance [137]
Transcriptional repressor CTCF (CTCF) OT8ZB70U CTCF_HUMAN Decreases Response To Substance [64]
Neuron navigator 3 (NAV3) OT97M1TR NAV3_HUMAN Affects Response To Substance [44]
Solute carrier family 22 member 18 (SLC22A18) OT9C3KR4 S22AI_HUMAN Decreases Response To Substance [128]
Gamma-interferon-inducible lysosomal thiol reductase (IFI30) OT9DERT1 GILT_HUMAN Decreases Response To Substance [64]
Apoptosis regulator Bcl-2 (BCL2) OT9DVHC0 BCL2_HUMAN Decreases Response To Substance [64]
Beta-glucuronidase (GUSB) OT9N1DK3 BGLR_HUMAN Affects Response To Substance [44]
FXYD domain-containing ion transport regulator 3 (FXYD3) OT9PPRHE FXYD3_HUMAN Increases Response To Substance [64]
Proteasome subunit beta type-6 (PSMB6) OT9VXPNW PSB6_HUMAN Affects Response To Substance [44]
High mobility group nucleosome-binding domain-containing protein 3 (HMGN3) OTA2TBWS HMGN3_HUMAN Affects Response To Substance [44]
Atypical chemokine receptor 3 (ACKR3) OTA6GA4F ACKR3_HUMAN Decreases Response To Substance [64]
Diphosphoinositol polyphosphate phosphohydrolase NUDT4B (NUDT4) OTA6ICI2 NUD4B_HUMAN Affects Response To Substance [44]
C-C motif chemokine 2 (CCL2) OTAD2HEL CCL2_HUMAN Increases Response To Substance [138]
Proteasome subunit alpha type-4 (PSMA4) OTAD2XXI PSA4_HUMAN Affects Response To Substance [44]
POM121 and ZP3 fusion protein (POMZP3) OTAH2JOK POZP3_HUMAN Affects Response To Substance [44]
Mediator of RNA polymerase II transcription subunit 4 (MED4) OTALFN4S MED4_HUMAN Affects Response To Substance [44]
snRNA-activating protein complex subunit 1 (SNAPC1) OTAPN1NI SNPC1_HUMAN Increases Response To Substance [128]
Collagen alpha-3(VI) chain (COL6A3) OTAS6R6I CO6A3_HUMAN Affects Response To Substance [44]
MAP kinase-activated protein kinase 5 (MAPKAPK5) OTAZHPVK MAPK5_HUMAN Affects Response To Substance [44]
Desmoplakin (DSP) OTB2MOP8 DESP_HUMAN Affects Response To Substance [44]
Large ribosomal subunit protein mL40 (MRPL40) OTB2QZDY RM40_HUMAN Affects Response To Substance [44]
Large ribosomal subunit protein uL16 (RPL10) OTBHOZGC RL10_HUMAN Affects Response To Substance [44]
Prominin-1 (PROM1) OTBHV8NX PROM1_HUMAN Decreases Response To Substance [139]
Probable ATP-dependent RNA helicase DDX23 (DDX23) OTBJHS8C DDX23_HUMAN Affects Response To Substance [44]
Coatomer subunit epsilon (COPE) OTBKHBT7 COPE_HUMAN Affects Response To Substance [44]
Protein FAM3C (FAM3C) OTBR6U9G FAM3C_HUMAN Affects Response To Substance [44]
Transmembrane protein 134 (TMEM134) OTBX9H9D TM134_HUMAN Affects Response To Substance [44]
Tight junction protein ZO-3 (TJP3) OTC1K8HC ZO3_HUMAN Decreases Response To Substance [128]
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) OTC1UOHP ATF3_HUMAN Affects Response To Substance [140]
Cyclin-dependent kinase 4 inhibitor C (CDKN2C) OTCLOV90 CDN2C_HUMAN Affects Response To Substance [44]
Cytochrome c oxidase copper chaperone (COX17) OTCP4LH2 COX17_HUMAN Affects Response To Substance [44]
Trefoil factor 1 (TFF1) OTCYQH4F TFF1_HUMAN Increases Response To Substance [64]
S-phase kinase-associated protein 2 (SKP2) OTD5B41X SKP2_HUMAN Affects Response To Substance [44]
Integrin alpha-1 (ITGA1) OTDITIST ITA1_HUMAN Increases Response To Substance [47]
Stathmin (STMN1) OTDJ4RV0 STMN1_HUMAN Affects Response To Substance [141]
Gamma-adducin (ADD3) OTDRSHAZ ADDG_HUMAN Affects Response To Substance [44]
Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A) OTDRV63V GA45A_HUMAN Decreases Response To Substance [64]
Superkiller complex protein 8 (SKIC8) OTDSQYDN SKI8_HUMAN Affects Response To Substance [44]
DNA-binding protein RFXANK (RFXANK) OTDX1026 RFXK_HUMAN Affects Response To Substance [44]
Transcription initiation factor TFIID subunit 1 (TAF1) OTDYS5G4 TAF1_HUMAN Affects Response To Substance [142]
EF-hand calcium-binding domain-containing protein 7 (EFCAB7) OTE0EG10 EFCB7_HUMAN Affects Response To Substance [44]
Glucose-6-phosphate isomerase (GPI) OTEGSRXG G6PI_HUMAN Affects Response To Substance [44]
GTP cyclohydrolase 1 feedback regulatory protein (GCHFR) OTEOT8GI GFRP_HUMAN Decreases Response To Substance [128]
Tyrosine-protein phosphatase non-receptor type 13 (PTPN13) OTESFZSO PTN13_HUMAN Increases Response To Substance [128]
Rho GDP-dissociation inhibitor 1 (ARHGDIA) OTEXWJDO GDIR1_HUMAN Affects Response To Substance [143]
Caveolin-1 (CAV1) OTEZUR1L CAV1_HUMAN Increases Response To Substance [64]
Serglycin (SRGN) OTFAVSX0 SRGN_HUMAN Affects Response To Substance [44]
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PIK3C2A) OTFBU4GD P3C2A_HUMAN Affects Response To Substance [44]
Laminin subunit alpha-2 (LAMA2) OTFROQWE LAMA2_HUMAN Increases Response To Substance [47]
Squalene synthase (FDFT1) OTGDISIT FDFT_HUMAN Affects Response To Substance [44]
Cytotoxic granule associated RNA binding protein TIA1 (TIA1) OTGPN3P8 TIA1_HUMAN Affects Response To Substance [44]
Stanniocalcin-1 (STC1) OTGVVXYF STC1_HUMAN Affects Response To Substance [44]
Gasdermin-D (GSDMD) OTH39BKI GSDMD_HUMAN Affects Response To Substance [87]
Low-density lipoprotein receptor (LDLR) OTH559LU LDLR_HUMAN Affects Response To Substance [44]
Cytochrome P450 2C8 (CYP2C8) OTHCWT42 CP2C8_HUMAN Increases Response To Substance [46]
Catalase (CAT) OTHEBX9R CATA_HUMAN Increases Response To Substance [144]
Metallothionein-2 (MT2A) OTHOACHD MT2_HUMAN Increases Response To Substance [64]
Neurogenic locus notch homolog protein 1 (NOTCH1) OTI1WADQ NOTC1_HUMAN Decreases Response To Substance [145]
Interstitial collagenase (MMP1) OTI4I2V1 MMP1_HUMAN Affects Response To Substance [44]
G2/mitotic-specific cyclin-B2 (CCNB2) OTIEXTDK CCNB2_HUMAN Affects Response To Substance [44]
Polycystin-2 (PKD2) OTIXBU8H PKD2_HUMAN Increases Response To Substance [128]
G/T mismatch-specific thymine DNA glycosylase (TDG) OTJB0YIH TDG_HUMAN Affects Response To Substance [44]
E3 ubiquitin-protein ligase FANCL (FANCL) OTJC7QPQ FANCL_HUMAN Affects Response To Substance [44]
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (PLCE1) OTJISZOX PLCE1_HUMAN Decreases Response To Substance [128]
Transmembrane protein 168 (TMEM168) OTJKZ6G9 TM168_HUMAN Affects Response To Substance [44]
Plakophilin-2 (PKP2) OTJOVF68 PKP2_HUMAN Decreases Response To Substance [128]
C-X-C chemokine receptor type 6 (CXCR6) OTK9R50G CXCR6_HUMAN Decreases Response To Substance [64]
Tyrosine-protein kinase receptor UFO (AXL) OTKA2SUX UFO_HUMAN Increases Response To Substance [128]
NADH dehydrogenase 1 alpha subcomplex subunit 1 (NDUFA1) OTKBUQXP NDUA1_HUMAN Affects Response To Substance [44]
CCN family member 1 (CCN1) OTKJBEMD CCN1_HUMAN Increases Response To Substance [128]
Serine/threonine-protein kinase PLK2 (PLK2) OTKMJXJ8 PLK2_HUMAN Increases ADR [34]
Galectin-4 (LGALS4) OTKQCG0H LEG4_HUMAN Decreases Response To Substance [128]
Methylsterol monooxygenase 1 (MSMO1) OTKV62RZ MSMO1_HUMAN Affects Response To Substance [44]
Leukocyte surface antigen CD47 (CD47) OTLDZ0KZ CD47_HUMAN Decreases Response To Substance [64]
Pyruvate kinase PKM (PKM) OTLHHMC2 KPYM_HUMAN Affects Response To Substance [44]
Transcription factor E2F1 (E2F1) OTLKYBBC E2F1_HUMAN Increases Response To Substance [129]
Glutathione S-transferase P (GSTP1) OTLP0A0Y GSTP1_HUMAN Increases Response To Substance [46]
Peptidyl-prolyl cis-trans isomerase B (PPIB) OTLPH6KN PPIB_HUMAN Affects Response To Substance [44]
Annexin A8 (ANXA8) OTLSSQCY ANXA8_HUMAN Increases Response To Substance [128]
Keratin, type II cytoskeletal 7 (KRT7) OTLT3JFN K2C7_HUMAN Increases Response To Substance [128]
Lysosome-associated membrane glycoprotein 2 (LAMP2) OTLUGEJC LAMP2_HUMAN Affects Response To Substance [44]
Peroxiredoxin-2 (PRDX2) OTLWCY9T PRDX2_HUMAN Affects Response To Substance [44]
Hemicentin-1 (HMCN1) OTLZAS0P HMCN1_HUMAN Increases Response To Substance [47]
Furin (FURIN) OTM2665Z FURIN_HUMAN Decreases Response To Substance [64]
NADH dehydrogenase iron-sulfur protein 8, mitochondrial (NDUFS8) OTMEAWKO NDUS8_HUMAN Affects Response To Substance [44]
Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (ALG8) OTMFG2YY ALG8_HUMAN Affects Response To Substance [44]
Glutathione S-transferase Mu 5 (GSTM5) OTMMBFY8 GSTM5_HUMAN Decreases Response To Substance [64]
Unconventional myosin-Va (MYO5A) OTMWLP3E MYO5A_HUMAN Increases Response To Substance [128]
Integral membrane protein 2B (ITM2B) OTMXEPXB ITM2B_HUMAN Affects Response To Substance [44]
Succinate--CoA ligase subunit beta, mitochondrial (SUCLA2) OTMZD4PW SUCB1_HUMAN Affects Response To Substance [44]
Four and a half LIM domains protein 1 (FHL1) OTN535SU FHL1_HUMAN Increases Response To Substance [128]
L-lactate dehydrogenase A chain (LDHA) OTN7K4XB LDHA_HUMAN Increases Response To Substance [146]
Proto-oncogene serine/threonine-protein kinase mos (MOS) OTNMQPFJ MOS_HUMAN Increases ADR [34]
Nuclear factor NF-kappa-B p105 subunit (NFKB1) OTNRRD8I NFKB1_HUMAN Increases ADR [34]
Calcium-activated potassium channel subunit alpha-1 (KCNMA1) OTNYXOZO KCMA1_HUMAN Affects Response To Substance [44]
G-protein coupled receptor 35 (GPR35) OTO23NRK GPR35_HUMAN Decreases Response To Substance [128]
Histone deacetylase 9 (HDAC9) OTO8O0LF HDAC9_HUMAN Increases Response To Substance [128]
Receptor tyrosine-protein kinase erbB-2 (ERBB2) OTOAUNCK ERBB2_HUMAN Decreases Response To Substance [147]
Arginine/serine-rich protein 1 (RSRP1) OTOAZLCL RSRP1_HUMAN Affects Response To Substance [44]
Malectin (MLEC) OTOPGRF5 MLEC_HUMAN Affects Response To Substance [44]
Oncostatin-M-specific receptor subunit beta (OSMR) OTORWHPL OSMR_HUMAN Increases Response To Substance [128]
E3 ubiquitin-protein ligase Mdm2 (MDM2) OTOVXARF MDM2_HUMAN Decreases Response To Substance [148]
Delta(24)-sterol reductase (DHCR24) OTP301JW DHC24_HUMAN Affects Response To Substance [44]
Interleukin-13 receptor subunit alpha-2 (IL13RA2) OTPC2G0X I13R2_HUMAN Affects Response To Substance [44]
DNA dC->dU-editing enzyme APOBEC-3C (APOBEC3C) OTPL0AI1 ABC3C_HUMAN Affects Response To Substance [44]
Prostaglandin E synthase 3 (PTGES3) OTPPQWI0 TEBP_HUMAN Affects Response To Substance [44]
Large ribosomal subunit protein uL23 (RPL23A) OTPYLCCX RL23A_HUMAN Decreases Response To Substance [64]
Aldo-keto reductase family 1 member C2 (AKR1C2) OTQ2XMO3 AK1C2_HUMAN Increases Response To Substance [64]
Eukaryotic translation initiation factor 5A-1 (EIF5A) OTQ8DJX5 IF5A1_HUMAN Increases Response To Substance [128]
Membrane cofactor protein (CD46) OTQ8NWJD MCP_HUMAN Increases Response To Substance [64]
Glutamine--fructose-6-phosphate aminotransferase 1 (GFPT1) OTQBDO45 GFPT1_HUMAN Decreases Response To Substance [128]
Clusterin (CLU) OTQGG0JM CLUS_HUMAN Decreases Response To Substance [149]
MAPK/MAK/MRK overlapping kinase (MOK) OTQK7M9V MOK_HUMAN Affects Response To Substance [44]
Keratin, type I cytoskeletal 23 (KRT23) OTQW6UAG K1C23_HUMAN Increases Response To Substance [47]
Fibroblast growth factor 5 (FGF5) OTQXGHBY FGF5_HUMAN Affects Response To Substance [44]
Solute carrier family 22 member 3 (SLC22A3) OTQYGVXX S22A3_HUMAN Affects Response To Substance [44]
Nuclear body protein SP140 (SP140) OTQZHFMT SP140_HUMAN Affects Response To Substance [44]
Transforming growth factor-beta-induced protein ig-h3 (TGFBI) OTR443C5 BGH3_HUMAN Decreases Response To Substance [47]
E3 ubiquitin-protein ligase CHFR (CHFR) OTRAD2TT CHFR_HUMAN Decreases Response To Substance [150]
Large ribosomal subunit protein mL63 (MRPL57) OTRB659E RT63_HUMAN Affects Response To Substance [44]
Protein CREG1 (CREG1) OTRHJ8HK CREG1_HUMAN Affects Response To Substance [44]
Acidic leucine-rich nuclear phosphoprotein 32 family member A (ANP32A) OTRHPFO2 AN32A_HUMAN Affects Response To Substance [44]
Retinol-binding protein 1 (RBP1) OTRP1MFC RET1_HUMAN Increases Response To Substance [128]
Receptor tyrosine-protein kinase erbB-3 (ERBB3) OTRSST0A ERBB3_HUMAN Decreases Response To Substance [128]
Aldo-keto reductase family 1 member B1 (AKR1B1) OTRX72TH ALDR_HUMAN Increases Response To Substance [128]
Arrestin-C (ARR3) OTRZ00CH ARRC_HUMAN Decreases Response To Substance [64]
MHC class I polypeptide-related sequence B (MICB) OTS2DVDW MICB_HUMAN Increases Response To Substance [128]
Latent-transforming growth factor beta-binding protein 2 (LTBP2) OTS88GSD LTBP2_HUMAN Affects Response To Substance [44]
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B) OTS9YK3E KCC2B_HUMAN Affects Response To Substance [44]
Lumican (LUM) OTSRC874 LUM_HUMAN Decreases Response To Substance [47]
Rhotekin (RTKN) OTSS8XR6 RTKN_HUMAN Decreases Response To Substance [151]
3-phosphoinositide-dependent protein kinase 1 (PDPK1) OTT09ZVP PDPK1_HUMAN Decreases Response To Substance [135]
Plasminogen activator inhibitor 1 (SERPINE1) OTT0MPQ3 PAI1_HUMAN Affects Response To Substance [44]
Collagen alpha-1(III) chain (COL3A1) OTT1EMLM CO3A1_HUMAN Decreases Response To Substance [47]
Lipopolysaccharide-induced tumor necrosis factor-alpha factor (LITAF) OTT5JX1F LITAF_HUMAN Affects Response To Substance [44]
Nucleophosmin (NPM1) OTTBYYT0 NPM_HUMAN Decreases Response To Substance [152]
Amyloid beta precursor like protein 2 (APLP2) OTTFE53M APLP2_HUMAN Affects Response To Substance [44]
Collagen alpha-1(XV) chain (COL15A1) OTTFKK18 COFA1_HUMAN Decreases Response To Substance [47]
Fascin (FSCN1) OTTGIHTM FSCN1_HUMAN Increases Response To Substance [128]
Keratin, type I cytoskeletal 13 (KRT13) OTTYSKGX K1C13_HUMAN Decreases Response To Substance [64]
Annexin A4 (ANXA4) OTUCRYXL ANXA4_HUMAN Decreases Response To Substance [153]
C-X-C chemokine receptor type 4 (CXCR4) OTUFSBX2 CXCR4_HUMAN Decreases Response To Substance [64]
N-acetylgalactosaminyltransferase 7 (GALNT7) OTUJSCAO GALT7_HUMAN Affects Response To Substance [44]
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (DAD1) OTUUNQBT DAD1_HUMAN Increases ADR [34]
Mitochondrial Rho GTPase 2 (RHOT2) OTV8WT2L MIRO2_HUMAN Affects Response To Substance [44]
Matrilin-2 (MATN2) OTVDR68G MATN2_HUMAN Decreases Response To Substance [47]
NADPH--cytochrome P450 reductase (POR) OTVIDOCH NCPR_HUMAN Increases Response To Substance [46]
Integrin beta-1-binding protein 1 (ITGB1BP1) OTVQFNGS ITBP1_HUMAN Affects Response To Substance [44]
U2 small nuclear ribonucleoprotein A' (SNRPA1) OTWJZFAP RU2A_HUMAN Affects Response To Substance [44]
Decorin (DCN) OTWLJL7K PGS2_HUMAN Decreases Response To Substance [47]
Glypican-3 (GPC3) OTWS8WSW GPC3_HUMAN Increases Response To Substance [47]
CASP8 and FADD-like apoptosis regulator (CFLAR) OTX14BAS CFLAR_HUMAN Decreases Response To Substance [154]
Transmembrane protein 59 (TMEM59) OTX4EKES TMM59_HUMAN Affects Response To Substance [44]
Nucleotide triphosphate diphosphatase NUDT15 (NUDT15) OTX8SZOT NUD15_HUMAN Affects Response To Substance [44]
Metallothionein-1E (MT1E) OTXJKU4Y MT1E_HUMAN Increases Response To Substance [64]
NADH dehydrogenase 1 alpha subcomplex subunit 3 (NDUFA3) OTXL10N9 NDUA3_HUMAN Affects Response To Substance [44]
Mitotic spindle assembly checkpoint protein MAD2A (MAD2L1) OTXNGZCG MD2L1_HUMAN Affects Response To Substance [136]
Neuroendocrine protein 7B2 (SCG5) OTXSJMT1 7B2_HUMAN Affects Response To Substance [44]
Peripheral myelin protein 22 (PMP22) OTXWYWCZ PMP22_HUMAN Decreases Response To Substance [64]
Collagen alpha-2(I) chain (COL1A2) OTY7G382 CO1A2_HUMAN Increases Response To Substance [47]
Bone morphogenetic protein 7 (BMP7) OTYATP2K BMP7_HUMAN Increases Response To Substance [64]
Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PPP1CB) OTYFTYFR PP1B_HUMAN Affects Response To Substance [44]
Ferritin light chain (FTL) OTYQA8A6 FRIL_HUMAN Decreases Response To Substance [64]
Proteasome subunit beta type-1 (PSMB1) OTYRFBAH PSB1_HUMAN Affects Response To Substance [44]
Procathepsin L (CTSL) OTYTUW29 CATL1_HUMAN Increases Response To Substance [64]
ADP-ribosylation factor 3 (ARF3) OTYYQX85 ARF3_HUMAN Affects Response To Substance [44]
V-type proton ATPase catalytic subunit A (ATP6V1A) OTYZ2S9E VATA_HUMAN Affects Response To Substance [44]
Mitochondrial import inner membrane translocase subunit Tim13 (TIMM13) OTYZQJD3 TIM13_HUMAN Affects Response To Substance [44]
Erythropoietin (EPO) OTZ90CN4 EPO_HUMAN Decreases Response To Substance [155]
Tissue factor pathway inhibitor 2 (TFPI2) OTZCRWOR TFPI2_HUMAN Affects Response To Substance [44]
Insulin-induced gene 1 protein (INSIG1) OTZF5X1D INSI1_HUMAN Affects Response To Substance [44]
C-X-C motif chemokine 5 (CXCL5) OTZOUPCA CXCL5_HUMAN Affects Response To Substance [44]
------------------------------------------------------------------------------------
⏷ Show the Full List of 478 DOT(s)

References

1 ClinicalTrials.gov (NCT00062010) Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7600).
3 Isotretinoin FDA Label
4 ClinicalTrials.gov (NCT04361422) Isotretinoin in Treatment of COVID-19. U.S. National Institutes of Health.
5 Paclitaxel FDA Label
6 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
7 Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol Ther. 2008 Oct;7(10):1607-18.
8 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
9 Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells. Reprod Toxicol. 2020 Jan;91:74-91. doi: 10.1016/j.reprotox.2019.10.004. Epub 2019 Nov 8.
10 Retinoic acid induces VEGF gene expression in human retinal pigment epithelial cells (ARPE-19). J Ocul Pharmacol Ther. 2005 Dec;21(6):413-9. doi: 10.1089/jop.2005.21.413.
11 Retinoid agonist isotretinoin ameliorates obstructive renal injury. J Urol. 2003 Oct;170(4 Pt 1):1398-402.
12 The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. Clin Pharmacol Ther. 2004 May;75(5):464-75.
13 Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. Toxicol Sci. 2006 Jul;92(1):51-60.
14 Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells. Leuk Lymphoma. 2005 Oct;46(10):1497-506.
15 Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo. Br J Cancer. 2007 Jun 4;96(11):1675-83.
16 Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2. Cancer Lett. 2005 Nov 18;229(2):271-81. doi: 10.1016/j.canlet.2005.06.047. Epub 2005 Aug 30.
17 Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. Toxicol Lett. 2015 Jan 5;232(1):193-202. doi: 10.1016/j.toxlet.2014.10.009. Epub 2014 Oct 16.
18 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am J Pathol. 2005 Jul;167(1):285-98. doi: 10.1016/S0002-9440(10)62973-2.
19 Differential regulation of Toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology. 2006;213(3):266. doi: 10.1159/000095056.
20 [Muscular damage during isotretinoin treatment]. Ann Dermatol Venereol. 1998 Feb;125(2):94-7.
21 Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphomas. J Formos Med Assoc. 1997 Jul;96(7):525-34.
22 Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteins. Mol Cancer Ther. 2010 Dec;9(12):3164-74. doi: 10.1158/1535-7163.MCT-10-0078.
23 Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. Brain Res Mol Brain Res. 2001 Feb 19;87(1):100-8. doi: 10.1016/s0165-3806(00)00154-1.
24 Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol. 2005 Oct;125(4):673-84. doi: 10.1111/j.0022-202X.2005.23848.x.
25 Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. Mol Biol Cell. 2006 Feb;17(2):566-75. doi: 10.1091/mbc.e05-06-0519. Epub 2005 Nov 9.
26 Expression of gastrointestinal glutathione peroxidase is inversely correlated to the presence of hepatitis C virus subgenomic RNA in human liver cells. J Biol Chem. 2005 Mar 11;280(10):8831-41. doi: 10.1074/jbc.M413730200. Epub 2004 Dec 28.
27 Chemical genomics profiling of environmental chemical modulation of human nuclear receptors. Environ Health Perspect. 2011 Aug;119(8):1142-8. doi: 10.1289/ehp.1002952. Epub 2011 May 4.
28 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol. 2006 Oct;126(10):2178-89. doi: 10.1038/sj.jid.5700289. Epub 2006 Mar 30.
29 All-trans-retinoic acid accelerates the differentiation of human B lymphocytes maturing into plasma cells. Int Immunopharmacol. 2005 Dec;5(13-14):1830-8. doi: 10.1016/j.intimp.2005.06.002. Epub 2005 Jun 21.
30 Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma. Mol Cancer Ther. 2007 Jan;6(1):70-81. doi: 10.1158/1535-7163.MCT-06-0125.
31 [Receptor-related mechanism of proliferation inhibilion and apoptosis induetion of human tongue squamous cell line Tca8113 by retinoids]. Di Yi Jun Yi Da Xue Xue Bao. 2005 Aug;25(8):935-41.
32 Pituitary specific retinoid-X receptor ligand interactions with thyroid hormone receptor signaling revealed by high throughput reporter and endogenous gene responses. Toxicol In Vitro. 2015 Oct;29(7):1609-18. doi: 10.1016/j.tiv.2015.06.018. Epub 2015 Jun 19.
33 A high-throughput screen for teratogens using human pluripotent stem cells. Toxicol Sci. 2014 Jan;137(1):76-90. doi: 10.1093/toxsci/kft239. Epub 2013 Oct 23.
34 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
35 Taking advantage of a side effect of isotretinoin. Arch Dermatol. 2003 Mar;139(3):376-7. doi: 10.1001/archderm.139.3.376.
36 Recombinant human glutathione S-transferases catalyse enzymic isomerization of 13-cis-retinoic acid to all-trans-retinoic acid in vitro. Biochem J. 1998 Nov 15;336 ( Pt 1)(Pt 1):223-6. doi: 10.1042/bj3360223.
37 Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines. J Gastroenterol. 2006 Feb;41(2):140-50.
38 Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukemia HL-60 cells. Acta Pharmacol Sin. 2004 Mar;25(3):378-84.
39 Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol Oncol. 2005 Jul;98(1):45-53. doi: 10.1016/j.ygyno.2005.04.010.
40 Changes of gene expression of thymidine phosphorylase, thymidylate synthase, dihydropyrimidine dehydrogenase after the administration of 5'-deoxy-5-fluorouridine, paclitaxel and its combination in human gastric cancer xenografts. Anticancer Res. 2008 May-Jun;28(3A):1593-602.
41 Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels. Cell Death Differ. 2000 Jun;7(6):574-86. doi: 10.1038/sj.cdd.4400688.
42 Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci. 2013 Nov;136(1):183-92. doi: 10.1093/toxsci/kft175. Epub 2013 Aug 16.
43 2-Methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells. Cancer Lett. 2006 Jan 8;231(1):49-64. doi: 10.1016/j.canlet.2005.01.018.
44 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
45 Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells. Prostate. 2005 Jan 1;62(1):61-8. doi: 10.1002/pros.20117.
46 Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes. Int J Cancer. 2004 Sep 10;111(4):617-26. doi: 10.1002/ijc.20289.
47 Microarray-based detection and expression analysis of extracellular matrix proteins in drug?resistant ovarian cancer cell lines. Oncol Rep. 2014 Nov;32(5):1981-90. doi: 10.3892/or.2014.3468. Epub 2014 Sep 9.
48 Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer. Sci Transl Med. 2011 Jan 26;3(67):67ra7. doi: 10.1126/scitranslmed.3001922.
49 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
50 Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6125-32.
51 Kinetics of P-glycoprotein-mediated efflux of paclitaxel. J Pharmacol Exp Ther. 2001 Sep;298(3):1236-42.
52 Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2). J Pharmacol Exp Ther. 2011 May;337(2):423-32.
53 Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]). J Pharm Pharmacol. 2005 May;57(5):573-8.
54 Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds. Eur J Med Chem. 2015 Mar 6;92:723-31.
55 Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer. Cancer Res. 2008 Jul 1;68(13):5380-9.
56 MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem. 2000 Aug 4;275(31):23530-9.
57 Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel. Cancer Biol Ther. 2005 Aug;4(8):815-8.
58 Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9. Oncol Lett. 2016 Nov;12(5):3905-3911.
59 Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7). Cancer Res. 2012 Dec 15;72(24):6457-67.
60 FaDu cell characteristics induced by multidrug resistance. Oncol Rep. 2011 Nov;26(5):1189-95. doi: 10.3892/or.2011.1418. Epub 2011 Aug 10.
61 Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head Neck. 2011 Jul;33(7):959-68. doi: 10.1002/hed.21559. Epub 2010 Aug 24.
62 MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int J Cancer. 2005 Sep 20;116(5):824-9. doi: 10.1002/ijc.21013.
63 Phosphatidylinositol 3'-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells. Cancer Res. 2004 Nov 15;64(22):8397-404. doi: 10.1158/0008-5472.CAN-04-1612.
64 cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance. Breast Cancer Res Treat. 2006 Mar;96(1):17-39. doi: 10.1007/s10549-005-9026-6. Epub 2005 Dec 2.
65 [Reversal effect of MDR1 and MDR3 gene silencing on resistance of A2780/taxol cells to paclitaxel]. Zhonghua Fu Chan Ke Za Zhi. 2007 Jun;42(6):412-6.
66 Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF kappaB-decoy transfer and transportal injection of paclitaxel, in mouse. Int J Cancer. 2008 Apr 1;122(7):1645-56. doi: 10.1002/ijc.23280.
67 The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol. 2009 Nov;175(5):2226-34.
68 Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF-7 human breast cancer cell line. J Biochem Mol Toxicol. 2021 Feb;35(2):e22638. doi: 10.1002/jbt.22638. Epub 2020 Oct 1.
69 Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther. 2004 Jan;3(1):71-84.
70 CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos. 2002 Jul;30(7):795-804.
71 A benzimidazole fungicide, benomyl, and its metabolite, carbendazim, induce aromatase activity in a human ovarian granulose-like tumor cell line (KGN). Endocrinology. 2004 Apr;145(4):1860-9.
72 The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Mol Endocrinol. 2005 May;19(5):1170-80.
73 Paclitaxel inhibits N-acetyltransferase activity and gene expression in human stomach tumor cells (SC-M1). Res Commun Mol Pathol Pharmacol. 2004;115-116:21-38.
74 Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation. J Am Coll Cardiol. 2009 Jun 16;53(24):2298-305.
75 Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes. Toxicol Appl Pharmacol. 2010 Feb 1;242(3):326-32.
76 Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci. 2010 Dec; 118(2):485-500.
77 Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res. 2001 Jan 15;61(2):759-63.
78 Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009 Aug 21;138(4):645-659. doi: 10.1016/j.cell.2009.06.034. Epub 2009 Aug 13.
79 Orlistat Displays Antitumor Activity and Enhances the Efficacy of Paclitaxel in Human Hepatoma Hep3B Cells. Chem Res Toxicol. 2019 Feb 18;32(2):255-264. doi: 10.1021/acs.chemrestox.8b00269. Epub 2019 Jan 22.
80 Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice. Apoptosis. 2007 Nov;12(11):2077-87. doi: 10.1007/s10495-007-0116-2. Epub 2007 Aug 16.
81 Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Mutat Res. 2007 Jun 1;619(1-2):16-29. doi: 10.1016/j.mrfmmm.2006.12.007. Epub 2007 Feb 8.
82 Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells. Cancer Biol Ther. 2005 Jul;4(7):716-9. doi: 10.4161/cbt.4.7.1782. Epub 2005 Jul 2.
83 Regulation of retinoschisin secretion in Weri-Rb1 cells by the F-actin and microtubule cytoskeleton. PLoS One. 2011;6(6):e20707. doi: 10.1371/journal.pone.0020707. Epub 2011 Jun 27.
84 Norcantharidin combined with paclitaxel induces endoplasmic reticulum stress mediated apoptotic effect in prostate cancer cells by targeting SIRT7 expression. Environ Toxicol. 2021 Nov;36(11):2206-2216. doi: 10.1002/tox.23334. Epub 2021 Jul 16.
85 CWF-145, a novel synthetic quinolone derivative exerts potent antimitotic activity against human prostate cancer: Rapamycin enhances antimitotic drug-induced apoptosis through the inhibition of Akt/mTOR pathway. Chem Biol Interact. 2016 Dec 25;260:1-12. doi: 10.1016/j.cbi.2016.10.014. Epub 2016 Oct 18.
86 Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer. Chem Biol Interact. 2020 Jan 5;315:108865. doi: 10.1016/j.cbi.2019.108865. Epub 2019 Oct 16.
87 The role of Caspase-1/GSDMD-mediated pyroptosis in Taxol-induced cell death and a Taxol-resistant phenotype in nasopharyngeal carcinoma regulated by autophagy. Cell Biol Toxicol. 2020 Oct;36(5):437-457. doi: 10.1007/s10565-020-09514-8. Epub 2020 Jan 28.
88 The vitamin A family can significantly decrease the expression of ERbeta of ERs positive breast cancer cells in the presence or absence of ER ligands and paclitaxel. Gynecol Endocrinol. 2009 May;25(5):287-93. doi: 10.1080/09513590802530924.
89 Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int. 2003 Apr;42(5):419-29. doi: 10.1016/s0197-0186(02)00132-8.
90 Protein kinase Cdelta-dependent induction of manganese superoxide dismutase gene expression by microtubule-active anticancer drugs. J Biol Chem. 1998 Dec 18;273(51):34639-45. doi: 10.1074/jbc.273.51.34639.
91 Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. 2004 Feb 7;25(3):94-102. doi: 10.1016/j.cyto.2003.10.004.
92 Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody. Cancer Immunol Immunother. 2003 Mar;52(3):185-93. doi: 10.1007/s00262-002-0357-4. Epub 2003 Feb 7.
93 pRb2/p130 decreases sensitivity to apoptosis induced by camptothecin and doxorubicin but not by taxol. Clin Cancer Res. 2004 Dec 1;10(23):8085-93. doi: 10.1158/1078-0432.CCR-04-0996.
94 Activator protein 2alpha status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy. Cancer Res. 2005 Oct 1;65(19):8628-34. doi: 10.1158/0008-5472.CAN-05-1059.
95 Genotoxic, cytotoxic, and apoptotic effects of Hypogymnia physodes (L.) Nyl. on breast cancer cells. Environ Toxicol. 2014 May;29(7):804-13. doi: 10.1002/tox.21809. Epub 2012 Aug 21.
96 ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells. Int J Oncol. 2004 Jun;24(6):1499-504.
97 Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J Biol Chem. 1999 Mar 19;274(12):8208-16. doi: 10.1074/jbc.274.12.8208.
98 Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. Cancer Res. 2010 Oct 15;70(20):7992-8002. doi: 10.1158/0008-5472.CAN-10-0585. Epub 2010 Aug 31.
99 Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression. Mol Neurodegener. 2006 Jul 26;1:6. doi: 10.1186/1750-1326-1-6.
100 Dieckol, a natural polyphenolic drug, inhibits the proliferation and migration of colon cancer cells by inhibiting PI3K, AKT, and mTOR phosphorylation. J Biochem Mol Toxicol. 2023 May;37(5):e23313. doi: 10.1002/jbt.23313. Epub 2023 Jan 22.
101 Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer. 2008 Feb 1;112(3):596-607. doi: 10.1002/cncr.23223.
102 Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer. Cancer Sci. 2010 Nov;101(11):2351-60. doi: 10.1111/j.1349-7006.2010.01671.x.
103 Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy. J Natl Cancer Inst. 2012 Mar 21;104(6):476-87. doi: 10.1093/jnci/djs002. Epub 2012 Feb 1.
104 Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells. Clin Cancer Res. 2003 Jun;9(6):2366-73.
105 Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin Cancer Res. 1999 Jul;5(7):1876-83.
106 Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway. Breast Cancer Res Treat. 2011 Jul;128(1):57-68. doi: 10.1007/s10549-010-1076-8. Epub 2010 Jul 28.
107 Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol. Apoptosis. 2008 Feb;13(2):259-71. doi: 10.1007/s10495-007-0165-6.
108 Development and applications of a real-time quantitative RT-PCR method (QRT-PCR) for BRCA1 mRNA. Clin Biochem. 2005 Jan;38(1):50-7. doi: 10.1016/j.clinbiochem.2004.09.012.
109 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
110 Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells. Toxicol Sci. 2010 May;115(1):118-30. doi: 10.1093/toxsci/kfq028. Epub 2010 Jan 27.
111 Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells (U-2 OS). J Orthop Res. 2005 Sep;23(5):988-94. doi: 10.1016/j.orthres.2005.01.018. Epub 2005 Apr 25.
112 Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells. Mol Pharmacol. 2001 Feb;59(2):254-62. doi: 10.1124/mol.59.2.254.
113 Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells. Toxicol Appl Pharmacol. 2006 Jan 1;210(1-2):55-62. doi: 10.1016/j.taap.2005.06.020. Epub 2005 Jul 26.
114 Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents. Biochem Pharmacol. 2005 Jul 1;70(1):13-21. doi: 10.1016/j.bcp.2005.04.017.
115 Synergistic interaction of lovastatin and paclitaxel in human cancer cells. Mol Cancer Ther. 2001 Dec;1(2):141-9.
116 PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol. Biochem Pharmacol. 2009 Apr 15;77(8):1348-57. doi: 10.1016/j.bcp.2009.01.008. Epub 2009 Jan 24.
117 Cell cycle G2/M arrest and activation of cyclin-dependent kinases associated with low-dose paclitaxel-induced sub-G1 apoptosis. Apoptosis. 1997;2(5):463-70. doi: 10.1023/a:1026422111457.
118 Interaction of cisplatin, paclitaxel and adriamycin with the tumor suppressor PTEN. Anticancer Drugs. 2001 Nov;12(10):797-800. doi: 10.1097/00001813-200111000-00002.
119 Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells. Toxicology. 2019 Aug 1;424:152231. doi: 10.1016/j.tox.2019.06.002. Epub 2019 Jun 4.
120 Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells. Biochem Pharmacol. 2010 Sep 15;80(6):884-94. doi: 10.1016/j.bcp.2010.04.018. Epub 2010 Apr 22.
121 Amyloid beta protein-related death-inducing protein induces G2/M arrest: Implications for neurodegeneration in Alzheimer's disease. J Neurosci Res. 2007 Aug 1;85(10):2262-71. doi: 10.1002/jnr.21351.
122 Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells. Mutat Res. 2011 Sep 18;724(1-2):76-85. doi: 10.1016/j.mrgentox.2011.06.003. Epub 2011 Jun 17.
123 3-hour infusion of single-agent paclitaxel for recurrent ovarian cancer. Int J Clin Oncol. 2001 Jun;6(3):128-31. doi: 10.1007/pl00012094.
124 Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs. Cancer Biol Ther. 2006 Apr;5(4):380-5. doi: 10.4161/cbt.5.4.2477. Epub 2006 Apr 4.
125 MM-TRAG (MGC4175), a novel intracellular mitochondrial protein, is associated with the taxol- and doxorubicin-resistant phenotype in human cancer cell lines. Gene. 2004 Sep 29;340(1):53-9. doi: 10.1016/j.gene.2004.06.013.
126 Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis. Mol Immunol. 2008 Mar;45(5):1470-6. doi: 10.1016/j.molimm.2007.08.013. Epub 2007 Oct 24.
127 High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res. 2010 Jul 1;70(13):5486-96. doi: 10.1158/0008-5472.CAN-10-0713. Epub 2010 Jun 8.
128 Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs. Cancer Sci. 2006 Jun;97(6):510-22. doi: 10.1111/j.1349-7006.2006.00204.x.
129 E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents. Cancer Res. 2006 Jul 15;66(14):7253-60. doi: 10.1158/0008-5472.CAN-05-3725.
130 Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer. Br J Cancer. 2008 Sep 2;99(5):760-7. doi: 10.1038/sj.bjc.6604528.
131 [Correlation of sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901]. Ai Zheng. 2008 Apr;27(4):337-42.
132 Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells. Oncotarget. 2016 Aug 9;7(32):52392-52403.
133 CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways. BMC Cancer. 2006 Mar 18;6:75. doi: 10.1186/1471-2407-6-75.
134 Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors. Pharm Res. 2006 Jun;23(6):1324-31. doi: 10.1007/s11095-006-0136-6. Epub 2006 Jun 8.
135 Differential roles of phosphoinositide-dependent protein kinase-1 and akt1 expression and phosphorylation in breast cancer cell resistance to Paclitaxel, Doxorubicin, and gemcitabine. Mol Pharmacol. 2006 Sep;70(3):1045-52. doi: 10.1124/mol.106.023333. Epub 2006 Jun 16.
136 Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy. Clin Oncol (R Coll Radiol). 2008 Oct;20(8):639-46. doi: 10.1016/j.clon.2008.06.010. Epub 2008 Aug 8.
137 Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats. Toxicology. 2016 Jul 15;365:48-58. doi: 10.1016/j.tox.2016.07.016. Epub 2016 Jul 27.
138 CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes. Anticancer Res. 2010 Dec;30(12):4791-8.
139 CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Mllerian tumor). Stem Cells. 2011 Oct;29(10):1485-95. doi: 10.1002/stem.711.
140 ATF3 inhibits arsenic-induced malignant transformation of human bronchial epithelial cells by attenuating inflammation. Toxicology. 2021 Aug;460:152890. doi: 10.1016/j.tox.2021.152890. Epub 2021 Aug 6.
141 Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer. Mol Cancer Ther. 2006 Dec;5(12):3248-57. doi: 10.1158/1535-7163.MCT-06-0227.
142 MIAT shuttled by tumor-secreted exosomes promotes paclitaxel resistance in esophageal cancer cells by activating the TAF1/SREBF1 axis. J Biochem Mol Toxicol. 2023 Aug;37(8):e23380. doi: 10.1002/jbt.23380. Epub 2023 May 3.
143 Reduced expression of Rho guanine nucleotide dissociation inhibitor-alpha modulates the cytotoxic effect of busulfan in HEK293 cells. Anticancer Drugs. 2007 Mar;18(3):333-40. doi: 10.1097/CAD.0b013e328011fd7f.
144 Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem Pharmacol. 2011 Nov 15;82(10):1384-90. doi: 10.1016/j.bcp.2011.06.007. Epub 2011 Jun 13.
145 Inhibition of the notch signaling pathway overcomes resistance of cervical cancer cells to paclitaxel through retardation of the epithelial-mesenchymal transition process. Environ Toxicol. 2021 Sep;36(9):1758-1764. doi: 10.1002/tox.23296. Epub 2021 May 28.
146 Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells. J Med Chem. 2011 Mar 24;54(6):1599-612. doi: 10.1021/jm101007q. Epub 2011 Feb 18.
147 Pculin02H, a curcumin derivative, inhibits proliferation and clinical drug resistance of HER2-overexpressing cancer cells. Chem Biol Interact. 2015 Jun 25;235:17-26. doi: 10.1016/j.cbi.2015.04.005. Epub 2015 Apr 10.
148 Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11636-41. doi: 10.1073/pnas.1934692100. Epub 2003 Sep 16.
149 Clusterin regulates drug-resistance in melanoma cells. J Invest Dermatol. 2005 Jun;124(6):1300-7. doi: 10.1111/j.0022-202X.2005.23720.x.
150 Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes. Int J Oncol. 2007 Oct;31(4):713-20.
151 Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis. Oncogene. 2004 Nov 18;23(54):8731-42. doi: 10.1038/sj.onc.1208106.
152 Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int J Oncol. 2014 Jul;45(1):448-58.
153 Current recommendations for systemic therapy of recurrent and/or metastatic head and neck squamous cell cancer. J Natl Compr Canc Netw. 2011 Jun 1;9(6):681-9. doi: 10.6004/jnccn.2011.0056.
154 Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel. Anticancer Res. 2005 May-Jun;25(3c):2367-79.
155 Erythropoietin protects sensory axons against paclitaxel-induced distal degeneration. Neurobiol Dis. 2006 Dec;24(3):525-30. doi: 10.1016/j.nbd.2006.08.014. Epub 2006 Sep 28.